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Developmental potency represents the ability of undifferentiated cells to undergo 
transformation into differentiated cells, with specialised functions. The inner cell mass 
(ICM) of a blastocyst represents the most developmentally potent cells of the body. The 
ICM, along with the naïve embryonic stem cells derived from it, possess remarkably 
low levels of global DNA methylation; a trait that is intrinsic to their pluripotent 
phenotype and when artificially induced can help re-programme differentiated cells 
back into a naïve state.  
Ten-eleven translocation (TET) enzymes actively remove DNA methylation in a 
Fe2+-dependent fashion. By assisting Fe2+ recycling, the antioxidant ascorbate has been 
shown to increase TET enzymatic activity and enhance reprogramming of 
differentiated cells to the naïve state. However, it is currently unclear if TET activation 
via ascorbate, or other antioxidants, can cause unwanted demethylation at imprint 
control regions; regulatory elements that control parent-of-origin specific gene 
expression. Loss of methylation at these regulatory groups results in the biallelic 
expression of the genes under their control. This phenomenon has been implicated in 
the formation of a range of cancers, as well as Beckwith-Wiedemann syndrome, a 
congenital overgrowth disorder. 
In this project, I aimed to test what effect the antioxidants ascorbate and 
hydroquinone have on the stability of imprint control regions through the activation of 
TET proteins, and in doing so, assess the safety and practicality of using naïve 
embryonic stem cells for future medical applications. I grew several naïve embryonic 
stem cell lines, including a TET triple knockout line with inducible TET expression, in 
varying concentrations of ascorbate or hydroquinone. Bisulfite amplicon sequencing 
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and florescence activated cell sorting techniques were used to assess methylation 
patterns at the KCNQ1ot1 imprinted loci in the presence or absence of increased TET 
activity.  
While the study has been hampered by technical difficulties (i.e. clonal 
amplification was detected, particularly in TET knockout cell lines), I have shown that 
ascorbate causes significant demethylation of the KCNQ1ot1 imprinted region at 25 
ng/μL of ascorbate. While other concentrations, (12.5 ng/μL and 50 ng/μL of ascorbate) 
were not statistically significant there appeared to be a trend of decreasing methylation 
which may have become more obvious had the cells been cultured with ascorbate for 
longer.  Interestingly this effect was not seen at 100 ng/μL of ascorbate, indicating there 
is an optimal concentration range for TET-induced demethylation at the KCNQ1ot1 
locus. In contrast, hydroquinone had no significant effect.  
Ultimately, these results add to the current literature describing the effects of 
different culture media constituents on naïve embryonic stem cells. This may allow for 
the rational design of culture media that can improve both the efficiency and safety of 
naïve embryonic stem cells and embryos used in regenerative medicine, mammalian 
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1 CHAPTER ONE: INTRODUCTION AND AIMS 
This introductory chapter describes the relevant literature and rationale for my research 
undertaken in 2018. Specifically, I will describe how the most developmentally potent 
cells of an embryo are captured and cultured in vitro. In particular, I will focus on a 
new technique that enables efficient reprogramming back to this naïve state through the 
use of DNA methylation removal enzymes, known as TETs. While promising, TET-
mediated reprogramming has several unexplored safety concerns, particularly around 
the integrity of genomic imprinting. These safety concerns will form the central point 
of this thesis.    
 
1.1 Developmental potency 
Developmental potency represents the ability of undifferentiated cells to undergo 
transformation into differentiated cells, with specialised functions. By definition, the 
first cell of a new organism (i.e. the fertilised egg, or zygote) must be ‘totipotent’, 
because it gives rise to all the cells of the embryo and the structures required to support 
its development. In some mammals (such as cattle and humans), this window of 
totipotency extends at least to the 2- and 4-cell stage because single cells from these 
embryos can be isolated and still create a viable organism (Veiga et al., 1987, Johnson 
et al., 1995).  
In contrast to totipotency, pluripotency in mammals is defined as the ability to 
create all cells of the embryonic body, but not the extraembryonic tissues required for 
in utero development (Martello and Smith, 2014). Cells within the centre of the mouse 
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blastocyst (i.e. the inner cell mass, or ICM for short) are known to possess pluripotency 
because they form the embryo proper, the only tissue within the blastocyst that 
contributes to the developed organism (Martello and Smith, 2014). 
To conceptualise the different developmental potential of cells within a growing 
organism, Conrad Waddington compared development to a hillside landscape. This 
idea, shown in Figure 1.1, uses a series of ridges and gullies as a metaphor to describe 
pathways of cell fate, and a marble rolling down any one gully as a representation of 
the trajectory a cell might take. Once a cell has entered a lineage pathway it is 
committed, as the ridges prevent it from entering any other gullies (Goldberg et al., 
2007, Hemberger et al., 2009). Using this example, totipotent cells are at the top of the 
landscape, with the potential to move down any gully and form any cell type.  
 
Figure 1.1 Waddington's Epigenetic Landscape.  
The marble at the peak of the landscape has several gullies, or cell lineages, it may roll down 
during development. The ridges prevent the marble from entering adjacent gullies, signalling 
that once a cell has entered a lineage pathway it has become committed to it, and cannot enter 
any others. The red circle indicates totipotent cells, while the green area indicates pluripotency. 
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Pluripotent cells cannot be placed at one point on the landscape but fall 
anywhere between the top peak and the initial gullies that represent formation into the 
three germ cell layers. Cells included in this definition can differ in gene expression and 
epigenetic characteristics (Nichols and Smith, 2009), leading to the idea that 
pluripotency comes in many ‘flavours’, with some cells (such as the ICM) considered 
more pluripotent than others – a concept first proposed by Nichols and Smith, 2009. 
 
1.2 Pluripotent cell culture 
The ability to harness the developmental potency of stem cells opens the door 
for drastic improvements in regenerative medicine or mammalian transgenics. Indeed, 
multipotent haemopoietic stem cell transplantations are already used to treat many 
types of leukaemia and lymphoma (Passweg et al., 2012), some genetic diseases such 
as beta-thalassemia (Morris et al., 2006), and have been described as an effective 
treatment for HIV/AIDS (Younan et al., 2013, Hutter et al., 2009). However, cells 
higher up the developmental hierarchy clearly have more flexibility and power; thus, 
culture of totipotent or pluripotent cells that can be directed to make a variety of tissues 
or cell-types would be extremely valuable for regenerative medicine. In addition to this, 
the potential uses of totipotent and pluripotent cells are not limited to a clinical setting. 
These cell types can offer great insight into the inner workings of mammalian 
development, furthering our understanding of how a single cell generates an entire 
organism. While it is currently not possible to culture totipotent cells (Lu and Zhang, 
2015), pluripotent cell culture has been employed in developmental biology labs in 
various forms since the 1950s (Solter, 2006). 
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This next section will cover the history of pluripotent cell culture from their 
conception up until the current day, and while doing so will explain the need for naïve   
pluripotent stem cells as opposed to classically derived ‘primed’ pluripotent stem cells. 
 
1.2.1 Classical pluripotent cell culture 
1.2.1.1 Mice and other Mammals 
With mice as the model organism of choice, pluripotent cell culture has been around 
since the 1950s in the form of embryonal carcinoma (EC) cells. These cell lines, as 
their name suggests, were derived from carcinomas; more specifically, 
teratocarcinomas. These tumours contain a mixture of differentiated cell types, 
including all three germ-layers, which were extracted and cultured ex vivo (Solter, 
2006). Due to their cancerous origin, these cells often presented with abnormal 
karyotypes. While this made them inappropriate for clinical applications, they were 
used as an early tool to study developmental processes.  
The culture of pluripotent stem cells was revolutionised in 1981 by Evans and 
Kaufman, (1981) and Martin, (1981), who independently produced cell lines directly 
from the pre-implantation embryo of mice. These cultured cells were called embryonic 
stem (ES) cells, and had a normal karyotype, could be maintained indefinitely, and 
could easily be injected back into a blastocyst to produce a functional chimeric mouse. 
For the first time, stable pluripotent cells had been cultured. It was soon recognised that 
genetic manipulations produced in ES cells could be passed on to adult mice if they 
were injected into blastocysts and formed the germline of the resulting mouse 
(Doetschman et al., 1987; Kuehn et al., 1987). This soon led to the creation of the first 
‘knockout’ mouse strain (Koller et al., 1990), which enabled researchers to more 
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effectively study disease and early developmental processes by inactivating genes of 
interest and observing the effect, but also allows for the construction of transgenic 
animals by directly inserting genes into the genome through either viral vector or 
homologous recombination (Palmiter and Brinster, 1986, Capecchi, 1989). To this day, 
the vast majority of knockout mice have been produced using ESC technology, 
culminating in perhaps the most remarkable example of genetic manipulation whereby 
successive rounds of genetic manipulation have resulted in the replacement of the entire 
mouse antibody system with that of a human (Lee et al., 2014a).  
Despite these initial ground-breaking advancements, ES cell utilisation was 
hampered by some serious limitations. Firstly, the original ES cell culture system 
required a fibroblast feeder cell layer, and the media used relied upon undefined (and 
likely variable) factors present within foetal bovine serum (FBS) (Evans and Kaufman, 
1981). While reliance upon feeder cells could be largely circumvented by 
supplementation of media with leukaemia inhibitory factor (LIF) (Smith et al., 1988, 
Williams et al., 1988), only in recent years has it been possible to remove reliance upon 
FBS in culture (Ying et al., 2008). But perhaps most importantly, early ES cell culture 
was limited because only a portion ES cells grown within classical media conditions 
contain recognisably pluripotent cells. This was first discovered by analysis of the 
pluripotency marker NANOG (Chambers et al., 2007), whose expression fluctuates in 
ES cell culture, with those NANOG negative cells showing some form of 
differentiation. Later it was shown that other pluripotency-related transcription factors 
such as REX1, ESRRB and OCT4 show similar heterogeneous expression patterns 
(Wray et al., 2010). The implication of this is that because some cells lack pluripotency 
factors, and are apparently ‘primed’ for differentiation, cells cultured in this classical 
media condition do not possess the complete, or ground state level, pluripotency seen in 
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the ICM. This heterogeneity is likely due to the undefined culture media, where each 
cell is experiencing its own unique microenvironment, and therefore varying amounts 
of pro or anti differentiation signals (Wray et al., 2010). It is possible that this 
heterogeneity is responsible for perhaps the most significant drawback of the original 
ES cell culture system; that is, it appears stem cell lines can only be derived in certain 
situations. For example, while researchers could derive lines from the 129-mouse 
strain, or related hybrids strains, relatively easily, it was difficult or impossible to do so 
from other mouse strains, let alone other mammals (Gardner and Brook, 1997). This 
presented a major barrier to perhaps one of the more useful applications of ES cells, 
namely mammalian transgenics. If ES cells are ever to be used in this context, they 
must be produced from animals other than mice. 
1.2.1.2 Humans 
Perhaps the greatest promise of ES cells, even more so than applications of mammalian 
transgenics, is regenerative medicine in humans. To do this, human ES cells must be 
produced. Using classical ES cell culture techniques, Thomson et al., (1998) produced 
what they described as the first human ‘ES’ cells using embryos donated from in vitro 
fertilization (IVF) patients. These were grown on mouse embryonic fibroblast feeder 
cells, with selection and growth of individual colonies resembling human EC cells over 
several passages. These cells demonstrated pluripotency through teratoma formation 
upon injection into mice. However, Thompson’s ES cells were found to have 
undergone X-chromosome inactivation, a characteristic associated with the late stage, 
post-implantation epiblast. Therefore, it is hard to consider these true ES cells, as they 
represent a much more differentiated stage of development than the already well-




1.2.2 Naïve ES cells – Culturing the ground state of pluripotency 
As previously mentioned, pluripotency can exist in several metastable states. It is clear 
that mouse and human ES cells grown in regular serum-based media, while displaying 
many pluripotency-related features, do not represent the most naïve, or ground-state of 
pluripotency. This is because some or all cells within these cultures display markers of 
early differentiation such as X-chromosome inactivation or have lost expression of 
pluripotency-related transcription factors such as NANOG (Nichols and Smith, 2009). 
Subsequent research efforts focussed upon media conditions which better capture the in 
vivo state of mammalian embryos, specifically the ICM, and have claimed to capture 
the naïve pluripotency (Ying et al., 2008). 
1.2.2.1 Mice 
In 2008, ES cells were derived for the first time using a fully-defined media that was 
not reliant upon serum products such as FBS. The key technological advance allowing 
this was supplementation with two small molecules, known as ‘2i’, in combination with 
LIF (Ying et al., 2008).  This resulted in homogenous expression of pluripotency 
markers such as NANOG (Martello and Smith, 2014, Wray et al., 2010) and 
remarkably similar global DNA methylation patterns to that of the ICM in vivo – 
features not shared with classically grown serum ES cells (Ficz et al., 2013). As such, 
these cells are considered to possess naive pluripotency, thus earning the name naïve 
ES cells (Martello and Smith, 2014, Nichols and Smith, 2009, Wray et al., 2010, Ying 
et al., 2008). 
Mechanistically, 2i is comprised of two small molecule inhibitors. Specifically, 
CHIR99021, which is an inhibitor of GSK3β, and PD0325901, a potent MEK1 
inhibitor (Figure 1.2). MEK1 is an integral part of the fibroblast growth factor 4 
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(FGF4)/ERK pathway in mice (Ying et al., 2008). ES cells naturally express FGF4, 
which acts in an autocrine manner to induce activation of the ERK/MAPK – a critical 
pathway required for mesodermal and neural lineage differentiation. Inhibition of this 
pathway arrests ES cells in a state of naive pluripotency, with full expression of OCT4, 
NANOG and REX1 (Kunath et al., 2007). OCT4 and NANOG are essential for the 
formation of the ground state phenotype in naïve ES cells (Nichols and Smith, 2009, 
Nichols et al., 1998), and while REX1 has no functional advantage for pluripotency 
attainment, it is exclusively expressed in the pre-implantation embryo and thus a good 
marker for naïve pluripotency (Kalkan and Smith, 2014). Indeed, antagonism of this 
pathway is so important for naive ES cell self-renewal that it is considered an integral 
part of the ground state (Martello and Smith, 2014).  
Under normal conditions, GSK3β acts as an inhibitor for the Wnt signalling 
pathway through phosphorylation of the signal transducing protein, β-catenin. 
Phosphorylation targets β-catenin for ubiquitination and subsequent destruction (Aberle 
et al., 1997). GSK3β inhibition, through CHIR99021, enables β-catenin to increase the 
expression of many pluripotency related genes through the alleviation of a 
transcriptional repressor protein, T-cell factor 3 (Tcf3) (Wray et al., 2011). Specifically, 
Esrrb expression is increased, and through interactions with other core pluripotency 
factors such as NANOG, OCT4, SOX2, and KLF4 (Martello et al., 2012), drastically 
increases self-renewal and growth, while inhibiting neural differentiation (Ying et al., 
2008).  
Interestingly, PD0325901 alone leads to progressive degeneration of ES cells, 
while CHIR99021 alone actively promotes non-neural differentiation. However, when 
CHIR99021 and PD0325901 are supplemented together the differentiation effect of 
CHIR99021 is erased by the inhibitory effects of PD0325901 and the promotion of self-
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renewal by CHIR99021 prevents degeneration (Ying et al., 2008). Thus, only the 
combination of both components of 2i can derive naïve pluripotency from classical ES 
cells. 
 
Figure 1.2. 2i signalling 
2i, comprised of the two inhibitors CHIR99021 and PD0325901, drives naive pluripotency 
through the inhibition of GSK3-β and MEK respectively, allowing for the transcription of 
pluripotency associated genes. 
Not only does this discovery help to further the understanding of mammalian 
development, it has also helped to overcome many of the limitations of classical ES 
cells. Most importantly, naïve ES cells can be cultured from a wider range of 
organisms, not just the 129-mouse strain. All strains of mice (Ying et al., 2008), as well 
as the rat (Li et al., 2008), can be used to obtain naïve ES cells, allowing for full genetic 
manipulation of both species. This has the potential to greatly improve the scope of 
biomedical research, as rats have significant benefits over mice as a model organism in 
many biological investigations (Iannaccone and Jacob, 2009). Further excitement from 
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the perspective of regenerative medicine is generated by the possibility of creating 
naïve pluripotent stem cells from human or non-rodent models.  
 
1.2.2.2 Humans 
Naïve ES cells have been derived from human blastocysts and classical human ES cells 
lines (i.e. those first derived by Thomson et al, 1998), although this was not as easy to 
achieve compared with mouse. Initial attempts focussed upon 2i media, but relied upon 
forced expression of pluripotency-related transgenes in order to create a naïve-like 
state. Subsequent attempts to remove the transgenes resulted in successful culture 
(Gafni et al., 2013, Theunissen et al., 2014), however, this requires a combination of 
factors in addition to standard 2i media. For example, Naïve Human Stem Cell (NHSC) 
media developed by the Hanna laboratory contains 2i as well as FGF-2, TGF-1β, a p38 
inhibitor, and JNK inhibitor. Interestingly, whilst FGF-2 is required for the 
maintenance of the naïve state in humans (Gafni et al., 2013), in mice FGF-2 induces 
differentiation via activation of the ERK pathway (Ying et al., 2008).  This highlights 
that despite their similarities, naïve ES cells in mice and humans have important 
biological differences that must be considered when using mice ES cells as a model for 
human health or disease.  
 Despite the recent derivation of naïve human ES cells, they are already showing 
great potential as an option for regenerative medicine. Recently, human ES cell lines 
have shown promise in treating wet age-related macular degeneration, a condition in 
which leaky blood vessels grow underneath the retina and excess fluid damages 




1.2.3 Reprogramming to the ground state 
In humans, and mice, forced expression of four key pluripotency related 
transcription factors (c-myc, SOX2, Oct4, and Klf4) can produce induced pluripotent 
stem cells (iPSCs) from differentiated adult cells (Takahashi and Yamanaka, 2006). 
iPSCs have several benefits over ES cells for regenerative medicine, including a 
reduced chance of tissue rejection because the cells are derived directly from the patient 
requiring treatment (Takahashi and Yamanaka, 2006). Ethical considerations are also 
lessened with iPSCs when compared to ES cells. This comes from the fact that ES cell 
lines must be derived from an otherwise normally developing embryo, destroying it in 
the process (Evans and Kaufman, 1981). Jung (2009) describes the current debate on 
whether or not human ES cells can be classified as a person, and thus whether or not we 
have the right to destroy these embryos to generate ES cell lines. It is unlikely that this 
debate will be resolved in the near future, meaning there is the potential for individuals 
to object to ES cell therapies based upon their own moral viewpoints. Thus, a focus on 
reprogramming cells back to a naive state of pluripotency may be required to help 
ensure the best health outcomes, both from a social and biological standpoint. 
While iPSCs represent an exciting prospect with respect to regenerative, as a 
model system they are somewhat difficult to work with. Principally, it can take over 1 
month to reprogram differentiated cells to the pluripotent state. Epiblast-like stem cells 
(EpiSC) resemble the post-implantation gastrulating embryo and can be reprogrammed 
to induced pluripotent stem cells (iPSCs) within just a few days following forced 
expression of at least one component of the core pluripotency circuitry network (e.g. 
Nanog, Klf4, Klf2, or Esrrb (Martello and Smith, 2014)) and 2i conditions. Yet, this 
process is inefficient, with reprogramming rates below 1% (Guo et al., 2009). As such, 
they provide a useful tool to show iPSC derivation can be accelerated or improved. 
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1.3 Epigenetics and ground state pluripotency 
1.3.1 Naïve ES cells and the ICM 
Whole genome bisulfite sequencing is a useful tool that has been employed to assess 
global methylation patterns of both naïve and classical ES cells, as well as early 
blastocysts and differentiated adult tissues. This has revealed perhaps the most striking 
feature of naive ES cells: remarkably low global levels of DNA methylation. Only 25-
35% CpG dinucleotides throughout the genome are methylated (Ficz et al., 2013, 
Habibi et al., 2013). This contrasts with classically grown ES cells and adult cell 
lineages, which have ~75-80% global CpG methylation (Ficz et al., 2013, Habibi et al., 
2013, Hon et al., 2013). Furthermore, the pre-implantation ICM of a developing 
embryo in vivo shares the globally low DNA methylation pattern of naive ES cells 
(Smallwood et al., 2011), suggesting the two might be equivalent. This loss of 
methylation is characteristic of early mammalian embryos and is thought to ‘wipe the 
slate clean’ of epigenetic memory before building it up again as the embryo develops. 
This prevents acquired epigenetic marks from parental DNA from impacting the 
offspring (Lee et al., 2014b). Some regions are exempt from demethylation, such as 
imprint control regions (ICR), as proper methylation patterns here are extremely 
important for the growth and development of the embryo (Morison et al., 2005).  
 
1.3.2 Demethylation as a driver for naïve pluripotency 
Not only is low methylation correlated with naïve pluripotency, but it is also a driver of 
it. DNA methyltransferase triple knockout (DNMT-TKO) naïve ES cells are deficient 
in all three methyltransferase genes and cannot add methylation to CpG dinucleotides, 
and as a result, are dramatically hypomethylated. DNMT-TKO cells are resistant to 
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differentiation and retain expression of many pluripotency factors even after induction 
of differentiation (Schmidt et al., 2012). In some cases, differentiation can occur, but 
when treated with LIF, they readily revert back to the naive state (Schmidt et al., 2012). 
Consistent with these results is that DNMT3A and DNMT3B, along with their co-factor 
DNMT3L, are significantly low expression in 2i treatment, but upon switching to the 
classical serum culture method, are drastically upregulated (Habibi et al., 2013) – a 
phenomenon attributed to MEK inhibition by PD0325901 (Choi et al., 2017). Because 
these enzymes are responsible for de novo methylation (Ficz et al., 2013, Habibi et al., 
2013, Lee et al., 2014b), their low expression in 2i suggests that hypomethylation in the 
ground state, is at least in part, due to the inability of naïve ES cells to deposit new 
methylation marks. DNMT1 is responsible for maintenance of DNA methylation 
patterns and does so via recruitment to hemi-methylated loci by UHRF1 (Lee et al., 
2014b). While protein levels of DNMT1 and UHRF1 are not altered, they cannot 
sustain DNA methylation on their own in naïve ES cells. As a result, methylation is 
passively lost when it is not replaced after cell replication (Lee et al., 2014b, Habibi et 
al., 2013). Together, these data suggest that methylation is required for differentiation. 
TET family proteins are also suspected to be involved in the demethylation of 
naïve ES cells (Ficz et al., 2013). All TET proteins (TET1, TET2, and TET3) are α-
ketoglutarate and Fe(II) dependant dioxygenases. They have the ability to remove DNA 
methylation by oxidation of 5-methyl-cytosine (5mC) to 5-hydroxymethyl-cytosine 
(5hmC) (Ito et al., 2010, Tahiliani et al., 2009), shown in Figure 1.3a. In addition to 
this, TET1 has been shown to maintain ES cell self-renewal by upregulating NANOG 
expression though hypomethylation of its promotor region (Ito et al., 2010). 
Remarkably, both TET1 and TET2 also share DNA binding sites with NANOG and are 
recruited to these in a NANOG dependant manner (Costa et al., 2013). Many of these 
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loci are the promotor regions of pluripotency associated factors, the most prominent of 
these being Esrrb. This suggests a positive feedback loop between NANOG and TET, 
resulting in demethylation and expression of pluripotency factors, pushing the cell 
towards a pluripotent state (Costa et al., 2013). Indeed, culturing ES cells in 2i results in 
an upregulation of TET2 (Ficz et al., 2013), which could help drive this effect. 
Contrasting this, loss of proper TET activity within naïve ES cells drastically reduces 
their viability (Dawlaty et al., 2014), further supporting this idea.  
Therefore, the hypomethylation phenotype observed in naive ES cells is likely 
due to a combination of passive demethylation though failed maintenance after 
replication, along with active oxidation of 5mC by TET1/2, and the inability to deposit 
new methylation marks (Ficz et al., 2013). However, more importantly, the interactions 
between TET proteins and NANOG indicates that not only is pluripotency reliant on 
hypomethylation, but that hypomethylation is heavily modulated by the components of 
the pluripotency network (Costa et al., 2013, Lee et al., 2014b). This suggests that 
globally low DNA methylation and naive pluripotency are profoundly intertwined and 
that without this core feature, the ground state is difficult to reach. 
 
1.3.3 Inducing demethylation to drive naïve pluripotency 
It is clear that global hypomethylation and naïve pluripotency in ES cells are 
intrinsically tied, leading to the idea that actively inducing hypomethylation may be a 
pathway towards pluripotency (Hore et al., 2016). As stated above, reprogramming 
EpiSCs to a naive state of pluripotency is possible, however, the conversion rate is very 
low at less than 1% (Guo et al., 2009, Martello and Smith, 2014). Recently, increasing 
the expression and activity of the TET enzymes with two commonly available vitamins, 
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ascorbate (vitamin C) and retinol (vitamin A), has led to a significant increase in 
reprogramming efficiency (Hore et al., 2016). 
Vitamin C was discovered to enhance TET activity in 2013, however, it was 
thought to act as a bound co-factor to TET enzymes (Blaschke et al., 2013). This is not 
the case, as Hore et al, (2016) have shown that ascorbate acts as an antioxidant, 
reducing Fe(III) back to Fe(II), and indirectly boosting TET activity (Figure 1.3b). As 
such, any antioxidant which is capable of reducing Fe(III) can be used to enhance TET. 
From a range of tested antioxidants, vitamin C is the only one to have an impact 
without a prior incubation period in vitro, but many other antioxidants did prove to 
have an effect (Hore et al., 2016). Interestingly, hydroquinone, the antioxidant with the 
second largest effect reported by Hore et al., (2016) has also been reported to increase 
demethylation through TET enzyme activation in cancer cells (Coulter et al., 2013), 
providing further evidence that the presence of antioxidants enables TET-mediated 
demethylation.   
This advancement has the potential to drastically improve stem cell science and 
regenerative medicine, as reprogramming human cells to iPSCs may become much 
more efficient with the addition of antioxidants to culture media. Antioxidant 
supplementation may also result in reduced reliance on pluripotency factor 
overexpression when producing iPSCs, which may help reduce the abnormal and 





Figure 1.3 Enzymatic activity of TET proteins 
Adapted from Hore, T. A. (2017). (a)TET proteins remove DNA methylation by oxidation of 5-
methyl-cytosine (5mc) to 5-hydroxymethyl-cytosine (5hcm). Base excision repair of 5hcm after 
TET activity results in conversion back to cytosine. (b) Antioxidant treatment enhances Fe2+ 
recycling, resulting in increased TET activity and subsequent demethylation.   
 
1.3.3.1 Potential impacts on genomic imprinting stability  
 However, actively inducing hypomethylation has several associated risks that 
have not been fully explored – namely dysregulation at ICRs; cis-acting regulatory 
elements that control parent-of-origin specific gene expression. ICRs employ 
differential DNA methylation patterns between alleles to control which parental copy is 
expressed. This results in monoallelic gene expression in embryos, and later, in the 
adult. These imprints are established during gametogenesis (Morison et al., 2005), and 
while there appears to be natural lability in imprinted gene methylation in the cells of 
the ICM (Lee et al., 2018), methylation-dependant imprinting is maintained throughout 
an organism’s lifespan. However, recent evidence suggests that if severe 
hypomethylation occurs during this early labile stage, loss of imprinting cannot be 
restored (Lee et al., 2018). 
                
          
              
        
                                  
    
       
 
   
    
   
   
 
   
   
    
   
   
                     
                        
         
    
       
 
   
    
   
 
    
   
   




      




      




      
            
   
   




Loss of imprinting (LOI) is often found at a high frequency in at least 14 
different cancers (Jelinic and Shaw, 2007). More specifically, LOI is seen in 100% of 
chronic myeloid leukaemia cancers, and over 80% of all ovarian cancers (Jelinic and 
Shaw, 2007), signifying that epigenetic dysregulation is a prime driver of these two 
cancers. Almost all imprinted genes identified to date are either growth factors or their 
receptors (Jelinic and Shaw, 2007, Morison et al., 2005), suggesting that 
hypomethylation at these regions may result in an increased growth rate in affected 
cells. Thus, it is imperative that the stability of ICRs in ES cells is understood during 
re-programming with enhanced TET activity, as any cells with affected imprinting will 
be unsafe for regenerative medicine in humans and ineffective for mammalian 
transgenics.  
While there is some evidence that ICRs are protected from antioxidant induced 
TET activation, this has only been studied using ascorbate supplementation at a static 
concentration (Blaschke et al., 2013), but not with other antioxidants such as 
hydroquinone. In addition, prolonged MEK inhibition, as a result of 2i, can cause 
aberrant expression of imprinted genes and genome instability (Choi et al., 2017). 
Therefore, it is hypothesised that TET-induced hypomethylation may exacerbate this 
instability. Indeed, recent evidence shows that the combination of 2i and a serum free 
culture media containing vitamin C, known as KSR, drastically increases demethylation 
at ICRs when compared to 2i + FBS media (Lee et al., 2018).  
1.4 Research aims 
My research aimed to further investigate if antioxidant-induced TET activation can 
disrupt the stability of ICRs and result in abnormal biallelic expression of imprinted 
genes in ES cells. I hypothesised that by steadily increasing the concentration of 
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antioxidants such as ascorbate or hydroquinone within culture media, mouse ES cells 
would subsequently lose DNA methylation at imprint control regions in a dose 
dependant manor. 
To test this, I attempted to enhance TET activity by increasing Fe2+ recycling 
with various antioxidant treatments. Specifically, by using LIF + 2i conditions, I 
cultured the naïve ES cell line B6xSD7, as well as the TET triple knockout (TET TKO) 
cell line, in increasing amounts of ascorbate or hydroquinone before examining the 




2 CHAPTER TWO: MATERIALS & METHODS 
2.1 Cultured cells 
2.1.1 Mouse embryonic stem cells 
Four distinct mouse ESC lines were cultured for experimentation, two wild type 
and two knock out. The first, B6xSD7, is a wild type cell line derived from the 
blastocyst of a cross between C57BL6/JOlaHsd and a related congenic strain where the 
distal arm of chromosome 7 is from SD7. The original motivation behind the derivation 
of this cell line was to enable investigation of differentially methylated regions 
(DMRs). One such region is the KCNQ1ot1 locus, which in B6xSD7 harbours an 18 
base pair insertion in the maternal (C57BL/6), but not paternal (SD7), allele (Figure 
2.1a) (Krueger et al., 2012).  V6.5 is another wild type cell line employed in these 
experiments, derived from the inner cell mass of a C57BL/6 x 129/sv cross (Rideout et 
al., 2000).  C57BL/6 and 129/sv mouse strains differ at two single nucleotide positions 
in exons two and three of the imprinted gene Impact (Choi et al., 2017), allowing for 
identification of either the maternal (C57BL/6) or paternal (129/sv) allele (Figure 2.1b-
c). Two TET TKO cell lines were used for experimentation. TET TKO cell lines are 
derived from a C57BL/6 and 129/sv background and are deficient in all three TET 
enzymes, preventing any TET mediated demethylation. Specifically, this line originates 
from a C57BL/6 x 129/sv Tet1 knock out (KO) crossed with a 129/sv Tet3 KO line, 
producing a Tet1, Tet3 double knockout (DKO). Targeted Tet2 KO was then performed 
on the DKO line, producing the TET TKO line. All Tet genes contain missense 
mutations in their respective catalytic domains (Gu et al., 2011, Hu et al., 2014). A 
derivative of the TET TKO line was employed, TET TKO mTET1-CD. This line is 
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transfected with a catalytically active form of TET1, as well as the red fluorescence 





b                                                         c 
V6.5 Impact Exon 2                                           V6.5 Impact Exon 5
 
Figure 2.1 Allelic differences at targeted imprinted loci.  
(a) Section of sequence from the KCNQ1ot1 imprinted region showing a deletion and insertion 
in the maternal allele (C57BL6) (red) when compared to the paternal allele (SD7) (blue). (b) 
Section of sequence from the imprinted region Impact showing a SNP between the maternal 
allele (C57BL6) (red) and paternal allele (blue) (129/sv) in both exon 2 (left) and (c) exon 5 
(right). 
 
2.1.2 Cell culture, passaging, and harvesting 
Mouse embryonic stem cells were grown in either 24, 12, or 6-well plates, or 
90mm dishes (Culture dishes from Corning®) coated with 0.1% gelatin (G1890-1KG) 
and cultured with one of two Embryonic Stem cell Media (ESM) variations. The first is 
an FBS-based ESM supplemented with LIF either with or without 2i (serum + LIF or 
serum + 2i/LIF). The second is a chemically defined media consisting of N2 (Gibco 
17502-048) and B27 (Gibco 12587-101) supplements, as well as LIF and 2i (N2B27 + 
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2i/LIF). Recipes for both ESM variants can be found in supplementary Table 1 and 2. 
The 2i mixture can be found in supplementary Table 3. 
To prevent overcrowding, cultures were passaged once every two to three days. 
During passaging, cells were washed twice with phosphate buffered saline (PBS) to 
remove detached, dead cells and any remaining media. Next, cells were incubated with 
StemPro® Accutase® (A11105-01) (volume dependant on size of the plate, see 
supplementary Table 4) for five minutes at 37°C to dissociate all remaining colonies 
from the plate. Cells were collected in 15 mL falcon tubes containing 10mL PBS and 
mixed via pipetting up and down to further detach the cells from one another, before 
being pelleted by centrifugation at 10 RFC for five minutes. Supernatant was then 
aspirated, and cells were resuspended in the appropriate volume of ESM 
(supplementary Table 4) before subsequent re-plating.  
Upon completion of experiments, media was aspirated from wild type cell lines 
(B6xSD7 and V6.5), before being washed twice with PBS and lysed in 150uL of 
Guanidinium Isothiocyanate (GITC). Cell lysates were stored in the -20°C freezer until 
further use. TET TKO cell lines were harvested post fluorescence activated cell sorting 
(FACS).  
2.1.3 Cell treatments 
During ascorbate and hydroquinone variation experiments all cultured cells 
were grown in the presence of 2i. This results in the rapid genome-wide demethylation 
of ESCs (Habibi et al., 2013, Lee et al., 2014b), however DNA methylation at 
imprinted regions is initially protected over the first few passages, before also being 
lost (Choi et al., 2017). Therefore, there is a time window where genome wide 
demethylation has occurred, but imprinted region methylation is intact. To allow global 
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demethylation to occur, but to ensure imprint stability is maintained, all cultures were 
pre-incubated in 2i conditions for 168 hours (one week) before treatments began.  
It was imperative that all experiments were seeded with the same number of 
cells prior to ascorbate and hydroquinone treatment. This was performed via cell counts 
with a Neubauer haemocytometer. Firstly, cells were dissociated with Accutase, 
resuspended in PBS, and pelleted as described above. The supernatant was removed, 
and cells were once again resuspended in 10mL of PBS. After further mixing via 
pipetting, 15 μL of cell suspension was examined under a light microscope with a 
haemocytometer. All cells within the four large corner squares (0.1μL per square) were 
counted and averaged. This enabled an estimate of total cells in suspension, allowing 
accurate calculations in seeding densities (supplementary Table 5). 
Lastly, TET TKO mTET1-CD cultures were treated with 1 μM doxycycline 72 
and 24 hours prior to harvesting by FACS, respectively.  
2.1.4 Thawing and freezing cells 
Prior to use, all cell lines were stored in liquid nitrogen. All frozen cells were 
stored in a freezing buffer consisting of 75% serum + 2i/LIF ESM, 15% FBS, and 10% 
Dimethyl sulfoxide (DMSO). To thaw them, cells were removed from liquid nitrogen 
and quickly warmed to 37°C. Once thawed, cells were transferred to a 15mL falcon 
tube containing 10mL of PBS. The suspension was then pelleted, and supernatant 
aspirated. The appropriate volume of ESM was added depending on plate size 
(Supplementary Table 6), and cells resuspended. The suspension was then plated out 
onto cell culture plates coated with 0.1% gelatin.    
Cells were regularly frozen down to be used for later experiments. Once the 
cultures became confluent, cells were collected as described in section 2.1.2 Cell 
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culture, passaging and harvesting. Cell counts with a Neubauer haemocytometer 
(performed as described above in section 2.1.3 experimental preparation) were used to 
estimate cell concentration. One million cells were resuspended in 250 μL of freezing 
buffer before being transferred to Corning™ 1 mL Cryogenic Storage Vials and stored 
in the -80°C freezer until further use.  
 
2.2 Total nucleic acid extraction 
Both DNA and RNA from cultured cells, collectively referred to as total nucleic 
acid (TNA), were extracted using the Bio-on magnetic bead approach (Oberacker et al., 
2018). For each sample, 60 μL cell lysate, dissolved in GITC, was mixed with 40 μL 
TE (10 mM Tris-HCl pH 8.0, 1 mM EDTA) and diluted magnetic beads until 
homogenous. 80 μL of isopropanol was added, and samples were again mixed until 
homogenous, before being incubated at room temperature for one minute allowing 
nucleic acids to precipitate and bind to the magnetic beads. Samples were then placed 
on a magnetic rack for 5 minutes, allowing the beads to accumulate on the side of the 
tubes and the supernatant was discarded. To remove residual GITC, each sample was 
washed with 150 μL of isopropanol followed by two subsequent washes with 200 μL of 
70% ethanol. 70% ethanol was removed by allowing the beads to dry for 5 minutes. 
TNA was eluted by removing the samples from the magnetic stand and resuspending 
the beads in 50 μL of filter sterile Milli-Q  (FSMQ) water. This was followed by an 
incubation at room temperature for one minute, before reapplying the samples to the 
magnetic, and collecting the supernatant.     
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2.2.1 Bisulfite conversion 
Bisulfite conversion of DNA is a useful tool that enables the visualisation of 
DNA methylation at single base pair resolution. In short, bisulfite treatment results in 
deamination of cytosine residues, and subsequent transformation into uracil. However, 
cytosine methylation renders it resistant to conversion. During PCR, uracil is read as, 
and subsequently replaced by, thymine and throughout amplification. After sequencing, 
comparisons back to an untreated sequence are made to assess DNA methylation levels 
- only methylated cytosines remain following bisulfite treatment, while unmethylated 
cytosine will appear as thymine. 
Once TNA had been isolated, bisulfite conversion was carried out using the 
Zymo Research EZ-96 DNA Methylation-Direct kit (4x96rxn, D5044) according to the 
protocol provided. Following conversion, samples were used in either post bisulfite 
adaptor tagging (PBAT), or PCR to generate amplicon libraries.  
2.2.2 cDNA library generation 
First strand cDNA synthesis was performed by using the Thermo Scientific 
RevertAid Reverse Transcriptase (EP0441) kit as per the protocol provided. First strand 
synthesis was performed using random hexamer primers. Resulting cDNA was 




2.3 Primer sets 
All primers used had been designed for previous experimentation and were re-
used for the current experiments. Some primer sets contain the Otago index handle 
(Table 4), which are used to attach unique indexes for multiplex sequencing. All primer 
sets with this feature have the prefix ‘tag’ in their name.  
The primer set for the KCNQ1ot1 locus were originally used by Kreuger .,et al 
(2013), but contain the Otago indexing handle at the 5’ end (Table 2.1). Primers used 
for Impact exon 2 and exon 5 cDNA sequence amplification span the intron exon 
boundary for their respective exon and were previously employed in the Hore lab at the 
University of Otago. These primers also contain the Otago indexing handle at the 5’ 
end (Table 2.2). The primer sets used for Impact exon 2 and exon 5 genomic DNA 
amplification have been previously employed in the Hore lab at the University of Otago 
and contain no indexing handle (Table 2.3). 
Table 2.1 Tagged primers used for KCNQ1ot1 sequence amplification 




Table 2.2 Tagged primers used for Impact exon 2 and exon 5 cDNA sequence 
amplification. 








Table 2.3 Primers used for Impact exon 2 & exon 5 genomic DNA seqeunce amplification. 















Primers were suspended in the appropriate amount of TE buffer to produce a 200 
μM stock solution. A 20 μM working solution was produced by diluting the stock 
solution by a ratio of 1:10 with FSMQ water. All primers were stored in the -20°C 
freezer and thawed upon use.  
 
2.4 Polymerase chain reaction 
PCR was used to amplify targeted regions of interest for amplicon multiplex 
sequencing and Sanger sequencing. For multiplex sequencing, unique indexes must be 
added to each individual sample. This was performed using two successive rounds of 
PCR and required primers with the additional index handle at the 5’ end (Table 4). The 
first round of PCR used sequence specific primers to amplify target regions, while the 
second round used primers containing a unique six base pair index which could be used 
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to identify specific samples post sequencing. Figure 2.2 shows a schematic diagram of 
the two step PCR process. Indexing primer sequences can be found in supplementary 
Table 7 and 8. To prepare samples for Sanger sequencing a single round of PCR was 
performed using primers without the index handle.  
 PCR optimization was required for successful amplification of target regions. 
This included gradient PCR tests to determine the most optimal annealing temperature, 
changes in primer and template concentration to reduce primer dimer if any was 
present, changes to the elongation time to increase the yield of longer PCR products, 
and changes in cycle number to adequately attach sequencing indexes when 
appropriate. Specific changes are outlined in Chapter 3: Results when relevant, 
however, optimisation resulted in the PCR parameters outlined below. 
2.4.1 Thermal cycling parameters 
 Bisulfite converted DNA was amplified using the KAPA Taq ReadyMix PCR 
Kit (KR0354 – v7.16) as per the manufacturer’s instructions. The components of the 
PCR are listed in Table 2.6. All other PCRs were performed with the Phusion® High-
Fidelity (HF) DNA Polymerase (NEB, M0530L), following manufacturer’s 
instructions. The components of this reaction are listed in Table 2.5. 
 The KCNQ1ot1 locus amplification Thermal cycling was carried out using the 
following cycle parameters:   
92C, 2min; 25*(92C, 10s; 59C, 10s; 72C, 30s); 72C, 5min; 4C, infinite; 10**(92C, 10s; 
59C, 10s; 72C, 30s); 72C, 5min; 4C, infinite. 
The bolded step indicates a pause where indexes were added. 
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To amplify exon 2 and exon 5 from the Impact  locus for Sanger sequencing the 
following thermal cycling parameters were used: 
98°C, 2 min; 34*(98°C, 10 sec; 65°C, 10 sec; 72°C, 30 sec); 4°C ∞. 
When amplifying the same regions for multiplex sequencing the cycling parameters 
were changed to the following: 
98°C, 2 min; 28*(98°C, 10 sec; 65°C, 10 sec; 72°C, 30 sec); 4°C ∞; 5*(98°C, 10 sec; 
65°C, 10 sec; 72°C, 30 sec); 8 ∞. 
Bolded 4°C ∞ step is the hold stage where indexes are added. 
Table 2.5 KAPA polymerase chain reaction components 
KAPA 
Reagent Final conc 10uL reaction 
KAPA (2X) - 5 
Primer (Forward) 0.3 uM 0.15 
Primer (Reverse) 0.3 uM 0.15 
Template - 0.5 
Milli-Q H20 50-X 7.2 
Total - 10 
Index concentrations  
Forward priming index (FPI) 0.2 uM 0.2 




Table 2.6 Phusion polymerase chain reaction components 
Phusion (Finnzyme/NEB)  
Reagent Final conc 10uL reaction 
Buffer (HF buffer) 1X 2 
dNTPs (stock with 5mM each) 
(BIO-39025) 
200uM each 0.4 
Primer (Forward) 0.5uM 0.25 
Primer (Reverse) 0.5uM 0.25 
Template - 0.4 
Taq (Phusion) 0.02uM 0.1 
H20 50-X 6.8 
Total 50 10 
Index concentrations  
Forward priming index (FPI) 0.2 uM 0.2 




Figure 2.2 Addition of unique indexes PCR amplicons. 
To attach unique indexes to each strand of template DNA two successive rounds of PCR were performed. In the first round, primers containing both sequence 
complementary to the target strand (green), as well as an indexing ‘handle’ (blue) were used (2). Upon completion, the indexing handle has effectively been 
added to both the 5’ and 3’ end of the template amplicon. The second round uses primers containing sequence complementary to the indexing handle (blue), 
as well as a unique index which is different for both forward and reverse primers (red). Once the second cycle is complete, unique indexes have been attached 
to the original strand, resulting in amplicons that can be multiplex sequenced.       
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2.5 Agarose gel electrophoresis and extraction 
To analyse DNA and RNA integrity after extraction, and to visualise PCR 
product fragment size after amplification, agarose gel electrophoresis was employed. 
Agarose gel was prepared at 1% weight/volume in Tris/ Acetate/ EDTA (TAE) buffer. 
GelRed (Biotium 41003) was added at a ratio of 1/20,000 in order visualise DNA and 
RNA fragments under ultra violet (UV) light. PCR products were loaded into wells 
along with the 100-base pair Bioline HyperLadder™ (Supplementary Figure 6)  and 
run at 110V for 60 minutes. A UV light transilluminator was used to visualise and 
photograph DNA fragments. 
2.5.1 Gel extraction 
Gel extraction was carried out when purifying amplicons for multiplex 
sequencing in the cases where an excess of primer/index dimer was present. Agarose 
gels were prepared as described above, however, GelGreen (Biotium 41005) dye was 
used in place of GelRed at a concentration of 1/20,000. All samples for sequencing 
were pooled together and run in a single lane alongside a DNA ladder. Using a Midi 
LED Transilluminator, which can visualise GelGreen using blue light, fragments were 
excised from the gel using a scalpel. DNA extraction from the gel was carried out using 
the QIAquick Gel Extraction Kit protocol (Qiagen, cat. 28704) as per the 
manufacturer’s instructions. DNA was eluted in 30 μL of Buffer EB (10 mM Tris-HCl, 




2.6 Florescence activated cell sorting 
The TET TKO mTET1-CD cell line possesses a doxycycline dependant Tet-on 
inducible promotor which controls the expression of both the florescent protein 
mCherry, as well as a catalytically active form of TET1. In order to isolate cells that 
expressed a high level of active TET, as well as cells that had no active TET 
expression, florescence activated cell sorting was used.  
To prepare cells for FACS, all cultures were washed twice, dissociated with 
Accutase, re-suspended in PBS, and pelleted as described in section 2.1.2 Cell culture, 
passaging, and harvesting. Once pelleted, the supernatant was aspirated, and the cells 
were re-suspended in 500μL FACS buffer (PBS with 5% FBS and 1μM DAPI). Cell 
suspensions were mixed via pipetting to fully separate cells from one another, before 
being transferred to a new 15mL falcon tube through a 40μm strainer to remove any 
remaining cell clumps.  
 Cells were gated for five different parameters. Firstly, forward scatter height 
(FSC-H) vs forward scatter area (FSC-A) and side scatter height (SSC-H) vs side 
scatter area (SSC-A) were used to sort single cells and filter out any doublets. FSC-A 
vs SSC-A was used to select cells based on size, as any events outside these parameters 
are likely to be some kind of debris, either cellular or otherwise. SSC-A vs 4;6-
diamino-2-phenylindole (DAPI) was used as a gate for live cells, as DAPI can only 
cross a compromised cell membrane to bind DNA (Kim et al., 2004), thus DAPI 
positive cells were excluded. Lastly, cells were sorted on mCherry expression. Cells 
were mCherry negative if fluorescence levels were equal to the negative control and 
were mCherry positive if fluorescence was 103 above baseline levels. Cells were 
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collected in 96 well plates containing 120 μL of GITC, resulting in cell lysis 
immediately after sorting. 
 
2.7 Post-bisulfite adaptor tagging 
Post-bisulfite adaptor tagging (PBAT) is a technique used to assess the 
methylation status across the genome, however, unlike whole genome bisulfite 
sequencing, PBAT can be performed with very low cell numbers (Miura et al., 2012). 
The PBAT technique can accomplish this by preforming bisulfite treatment before the 
addition of adaptor sequences for sequencing. This contrasts with other whole genome 
bisulfite sequencing methods which typically treat libraries with bisulfite after the 
addition of adaptors, which can lead to degradation of libraries. 
Bisulfite conversion of genomic DNA (protocol described in 2.2.1 Bisulfite 
conversion), leaves it fragmented and single stranded. Thus, the first step was to 
synthesize a new strand, and attach the forward adaptor sequence. To do this, 19.5 μL 
of bisulfite treated DNA was mixed with 4 μL of first strand synthesis reaction mixture 
(Table 2.7). This mixture uses BioP5N7 as a primer for first strand synthesis. BioP5N7 
contains a biotin molecule attached to the forward Otago index handle (Table 2.4), with 
a further seven random nucleotides. Samples were then incubated at 65°C for 5 
minutes, then 4°C for 5 minutes, before addition of the DNA polymerase Klenow-exo 
(NEB, M0212L). All samples were then incubated at 4°C for 15 minutes, before the 
temperature was steadily increased at 6°C per minute until 37°C, where it remained for 




Table 2.7 PBAT first strand synthesis mixture 
Reagent Volume 
dNTP (5mM) (BIO-39025) 1 μL 
BioP5N7 (10 μM) 0.5 μL 
10x NEB Buffer2 (B70025) 2.5 μL 
Total 48 μL 
 
After first strand synthesis the only remaining single stranded DNA is excess 
adapter. Thus, each sample was treated with 1µL of Exonuclease I (NEB, M0293S) to 
remove nucleotides from single stranded DNA and to prevent any further adapter dimer 
formation. The 37°C incubation was then continued for 60 minutes. Upon completion, 
20 μL of PEG diluted solid phase reversible immobilization (SPRI) beads was added to 
each sample and mixed via pipetting. Samples were then left to incubate at room 
temperature for 1 minute to allow DNA to bind the beads before being placed onto a 
magnetic rack. The supernatant was aspirated, and samples were washed with 90% 
ethanol before being eluted into 100 μL of TE buffer. 
Purified DNA fragments were then captured on streptavidin coated Dynabeads® 
(Thermo Fisher Scientific, 11205D). To do this, 10 μL of Dynabeads were first placed 
onto a magnetic rack and supernatant aspirated to remove the original solution. The 
beads were then removed from the magnet and re-suspended in 100 μL of binding and 
washing buffer (10mM Tris-HCl (pH7.5), 1mM EDTA, 2M NaCl). DNA fragments 
were then mixed with the streptavidin coated Dynabeads and incubated at room 
temperature for 20 minutes with rotation to allow for biotin capture. Samples were then 
placed on a magnetic rack, and supernatant removed and discarded. 
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To prepare samples for second strand synthesis and the attachment of the reverse 
adaptor, samples were washed twice with 100 μL of 0.1M NaOH to denature the first 
strand, before two more additional washes with 100 μL of 10mM Tris. Each sample 
was then re-suspended in 48 μL of second strand synthesis reaction mixture (Table 2.8). 
This mixture uses BioP7N7 as a primer for first strand synthesis. BioP7N7 contains a 
biotin molecule attached to the reverse Otago index handle (Table 2.4), with a further 
seven random nucleotides. Samples were then incubated at 95°C for 45 seconds before 
being immediately transferred to ice and the addition of 1 μL of DNA polymerase 
Klenow-exo (NEB, M0212L). Incubation was then continued at 4°C for five minutes, 
before rising to 37°C at 6°C per minute, where it remained for a further 90 minutes. 
 
Table 2.8 PBAT second strand synthesis reaction mixture 
Reagent Volume 
dNTP (5mM) (BIO-39025) 2 μL 
BioP7N7 (10 μM) 2 μL 
10x NEB Buffer2 (B70025) 5 μL 
FSMQ water 39 μL 
Total 48 μL 
 
Upon completion, the supernatant was removed, and the beads were washed with 
50 μL of TE buffer before being re-suspended in 12 μL of PBAT PCR mixture (Table 
2.9). Amplification was carried out using the following thermal cycling parameters: 




Once amplification was complete, each sample was run on a 1% agarose gel to 
assess sample quality, before being stored at -20°C until pooling in preparation for 
sequencing.  
2 μL of each sample was pooled together into a single 0.2 mL PCR tube along 
with 2x the total volume of PEG diluted magnetic SPRI beads, only allowing fragment 
sizes above 200 base pairs to bind and eliminating all excess primer and polymerase. 
To ensure all DNA was bound to the beads samples were incubated at room 
temperature for 2 minutes before being placed onto a magnetic rack. The supernatant 
was aspirated, and beads were washed with 150 μL of 70% ethanol before being re-
suspended in half the original starting volume. All samples were then sequenced in 
multiplex using the Illumina MiSeq system. 
 
Table 2.9 PBAT PCR reaction mixture 
Reagent Volume 
KAPA HiFi HotStart Uracil+ Mix (2x) 
(KK2801) 
6 μL 
Forward priming index (FPI) (10µM) 0.5 μL 
Reverse priming index (RPI) (10µM) 0.5 μL 
FSMQ water 5 μL 





2.8 DNA sequencing 
2.8.1 Sanger sequencing 
Sanger sequencing was used to assess the single nucleotide polymorphism 
(SNP) profile in exon 2 and exon 5 of the Impact locus in the TET TKO mTET1-CD 
cell line. For amplicon sequencing, samples were first cleaned to remove excess dNTPs 
and enzymes. This was performed by mixing the PCR product with magnetic beads 
suspended in polyethylene glycol (PEG) at a ratio of 1:2 and incubating for 1 minute at 
room temperature to allow DNA to bind to the beads. Samples were then placed into a 
magnetic rack and the supernatant was aspirated and discarded. Each sample was 
washed with 70% ethanol twice, before being eluted into molecular grade water. 
Once samples had been cleaned, 1 ng of DNA per 100 base pairs of template 
sequence was combined with 3.6 μM of primer in a 5 μL reaction. Sequencing was 
performed by the Genetic Analysis Service at the University of Otago and analysis was 
performed using Chromas software. 
 
2.8.2 Illumina MiSeq 
KCNQ1ot1 amplicons and PBAT samples were sequenced using the Illumina MiSeq 
System with the MiSeq Reagent Kit (MS-102-3001). This enables high throughput 
sequencing of multiple samples at once, speeding up the sequencing process 
tremendously.  
The MiSeq Reagent Kit was stored at -20°C. In preparation for sequencing the 
reagent cartridge was removed from storage at least 1 hour before sequencing and 
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placed in room temperature FSMQ water to thaw. The hybridization buffer (HT1) was 
thawed and stored at 4°C until use.    
To prepare samples for sequencing cleaned libraries (using PEG diluted SPRI 
beads for PBAT libraries or by gel extraction for amplicon libraries) were diluted to 
4nM with FSMQ water. DNA was then denatured by combing 5μL library with 5μL of 
freshly prepared 0.2nM NaOH and mixing by vertex for 1-minute, before a 5-minute 
incubation at room temperature. Libraries were then diluted by adding 990μL of HT1 
resulting in a 20pM denatured library. The 20pM library can then be diluted further to 
obtain a specific cluster density. To obtain a cluster density of 800k/mm2, 240μL of 
20pM library was mixed with 360μL of HT1 to get a final concentration of 8pM.  
Finally, 600μL of sample library was loaded into the reagent cartridge reservoir. 
The reservoir, flow cell, and incorporation buffer were then loaded into the MiSeq 
System for sequencing to begin.  
 
2.9 Bioinformatics 
In order to process the large amount of data generated by high-throughput multiplex 
sequencing a bioinformatics pipeline was developed. This involved quality checking 
raw reads and trimming the adapter sequences, separation of maternal and paternal 
alleles, mapping reads to a reference sequence, and generating easy to understand 
graphs from data-heavy samples (Figure 2.3). 
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2.9.1 Quality control and adapter trimming 
2.9.1.1 FASTQC 
FASTQC is a quality control software developed by the bioinformatics group at 
Babraham Institute, England. This software provides an overview of raw data quality, 
including per base and per sequence quality scores, sequence length distributions, 
adapter content, and the presence of overrepresented sequences. Upon receiving 
sequencing results, all samples were checked in FASTQC for an indication of data 
quality and to identify any areas where problems might exist. This tool would be 
continually used to examine read quality throughout data analysis to monitor the quality 
of samples. For example, samples with high adapter content would be re-examined 
after adapter trimming to ensure all adapter sequences had been removed correctly.  
2.9.1.2 Adapter trimming 
Adapter sequences are required for cluster formation during sequencing, however, they 
must be removed prior to analysis. This is because unlike the template DNA, they have 
not undergone bisulfite conversion. Thus, in order for bisulfite conversion efficiency 
calculations to be accurate these sequences must be removed. To achieve this the 
‘TrimGalore’ program was used in conjunction with the UNIX command line. In 
essence, this program could loop through all the reads of a given sample and trim off a 
predetermined number of nucleotide calls equal to the length of the adapter sequence. 
2.9.2 Parent specific allele isolation and BISMARK mapping 
2.9.2.1 Parent specific allele isolation 
In order to (a) determine the number of maternal and paternal alleles per sample, and 
(b) assess parent specific methylation patterns, reads pertaining to either parent were 
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isolated and assessed individually where applicable (i.e TET TKO samples had no 
parent identifying features and thus separation was not possible).  
 To do this, regular expression patterns were identified and isolated using the 
grep command in the terminal command line. To preserve the FASTQ format of the 
files, one line above the regular expression, and two lines below, were also extracted. 
The following command was utilized to achieve this: 
grep -A 2 -B 1 ‘[regular expression]' [INPUT.fq] | sed '/^--$/d' > [output.fq] 
Parent-of-origin allelic makers are often situated in the middle of the amplicon; thus, 
their isolation has the added benefit of removing short, low quality reads that do not 
contain these markers but were not removed during the adapter trimming phase. 
2.9.2.2 BISMARK Mapping 
Once reads had been trimmed and parent specific reads had been isolated, the 
BISMARK mapping program was used to map reads to a reference sequence, allowing 
for identification of specific CpG methylation profiles. Output files were then extracted 
and processed by the SAMtools, converting them into a binary arrangement where each 
CpG location within a read was marked as either methylated or unmethylated.   
2.9.3 Graph production  
A custom R-script was developed to create easily readable images of the data. In short, 
this script would assess the methylation status at each CpG for each read, calculate the 
overall mean methylation across all reads in that sample, and produce a ‘salt and 
pepper’ heat map where methylated CpGs are displayed as a black square and 




Figure 2.3 Bioinformatics Pipeline 
Schematic showing the pipeline developed for analysis of bisulfite amplicon sequencing from 




3 CHAPTER THREE: RESULTS 
Inducing global DNA demethylation by enhancing TET enzyme activity is a useful 
technique to improve the reprograming efficiency of differentiated cells to a naïve 
pluripotent state (Hore et al., 2016). Nevertheless, too much TET activity could cause 
cells to lose methylation at imprinting control regions, resulting in loss of imprinting 
and biallelic gene expression.  
To test this possibility, mouse embryonic stem cells were cultured under 2i 
conditions and treated with varying concentrations of two antioxidants: ascorbate and 
hydroquinone. Following optimisation of PCR amplification for two imprinted loci, 
high-throughput bisulfite amplicon sequencing was used to assess the methylation 
patterns at the KCNQ1ot1 imprinted locus. While technical difficulties such as the 
detection of clonal amplification, particularly in the TET triple knockout cell line, 
hindered this study, I was able to show that the antioxidant ascorbate causes a dose 
dependant loss of methylation. However, most interestingly, at the higher concentration 
of 100 ng/μL of ascorbate, no loss of methylation was observed.  
 
3.1 PCR optimization 
To efficiently quantify methylation in a large number of samples, I performed multiplex 
bisulfite amplicon sequencing using the Illumina MiSeq platform. The power of 
multiplex library preparation lies in the paired-end 8-bp indexes that flank the region of 
interest – by using a unique combination of indexes for each sample, I was able to 
analyse >100 samples simultaneously. The indexes, as well as Illumina adapters (for 
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binding the sequencing flow-cell) were added to template DNA during a 2-step PCR 
amplification process (Figure 2.2). Due to the extreme length of the template several 
PCR optimisation experiments had to be performed in order to consistently generate 
high quality amplicon libraries.  
3.1.1 Cell culture 
Both V6.5 and B6xSD7 cell lines were chosen as candidate cell lines due to the parent-
of-origin specific allelic differences at the Impact and KCNQ1ot1 loci, respectively 
(Figure 2.1). The V6.5 cell line was observed to regularly form compact circular 
colonies typical of naïve embryonic stem cells (Ying et al., 2008) when cultured in 
either the FBS-based serum + 2i/LIF media or the chemically defined N2B27 + 2i/LIF 
media. There was no apparent change in in cell growth between either media condition. 
This is in contrast to the B6xSD7 cell line which was extremely sensitive to the N2B27 
+ 2i/LIF media, which often crashed within a few days of seeding. The chemically 
defined nature of N2B27 + 2i/LIF media offers greater control over media composition. 
Thus, the V6.5 cell line, and therefore the Impact locus, was the ideal first choice.  
3.1.2 Impact PCR optimisation  
 The Impact locus has two SNPs within the protein coding region, one in exon 2 
and another in exon 5 (Figure 2.1b). To assess the imprinting stability at this locus, I 
attempted to examine the relative expression patterns of each allele using reverse 
transcriptase PCR (RT-PCR). In order to determine the optimal annealing temperature, 
I performed a gradient PCR experiment using four different annealing temperature 
between 54°C and 65°C. I used tagged primers for Impact exon 2 and exon 5 cDNA 
amplification (Table 2.2) with the Phusion® High-Fidelity DNA Polymerase (Table 
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2.6), and cDNA from previously extracted V6.5 TNA. The following thermal cycling 
parameters were used:  
98oC, 2 min; 34*(98°C, 10 sec; 54-65°C, 10 sec; 72°C, 20 sec); 8°C ∞ 
The correct band size for both exon 2 (272 base pairs) and exon 5 (291 base pairs) 
confirmed successful amplifcation across all anneling tempretures. In addtion, non-
specific amplifcation was not seen within any of the anneling temperatures (Figure 3.1), 




Figure 3.1 Impact gradient PCR for round one amplification optimization  
Agarose gel electrophoresis analysis of the Impact exon 2 and exon 5 gradient PCR. Successful 
amplification for each region of interest across all temperature ranges is confirmed by the 
correct band size for both exon 2 (272 base pairs) and exon 5 (291 base pairs). Additional bands 




Once sucessful amplification had been observed with sequence specific primers, I 
attempted to attach unique indexes. It was possible that the indexing primers would 
have a different optimal annealing temperature than the sequence specific primers. 
Therefore I performed another gradient PCR experiment using the previous conditions, 
along with the addition of a second amplifcation cycle using unique indexing primers 
(supplementary Table 7 and 8). The following thermal cycling paramters, with the 
bolded 4°C pause step indicating the addtion of the unique indexing primers: 
98°C, 2 min; 28*(98°C, 10 sec; 65°C, 10 sec; 72°C, 30 sec); 4°C ∞; 5*(98°C, 10 sec; 
54-65°C, 10 sec; 72°C, 30 sec); 8 ∞. 
The addition of an extra band 65 base pairs above the original fragment height 
creates a ‘double band’ on the gel. This indicates the successful incorporation of 
indexes into most, but not all of the amplicons and was used as a marker for correct 
library generation. Upon completion of the indexing PCR only single bands were 
present, suggesting that the indexes had not been successfully incorporated at any of the 
temperature ranges (Figure 3.2a). It was hypothesized that the low number of cycles 
were responsible for this, thus the number of cycles was increased to 8. This resulted in 
apparent successful incorporation of indexes into exon 5 sequences at 61.48°C, but 
interestingly, not at the lower annealing temperature of 57.63°C. No amplification was 
observed for exon 2 (Figure 3.2c). Regardless, the Impact exon 5 libraries were 
sequenced. Unfortunately, for an unknown reason, these libraries did not return any 
reads. Therefore, due to time constraints and the availability of the B6xSD7 cell line the 












Figure 3.2 Impact gradient PCR for round two amplification optimization 
(a) Agarose gel eletorpheisis anaylsis for indexing gradeint PCR with 5 cycles post the additon 
of indexing primers. The presence of only one band (272 base pairs for exon 2, 291 base pairs 
for exon 5) indicates the unsuccessful addtion of unique indexes to the amplicons. (b) Negative 
control for exon 2 and exon 5 indexing gradient PCR. The band at 110 base pairs is presumed 
to be primer dimer. (c) Agarose gel electrophoresis anaylsis for indexing gradient PCR with 8 
cycles post the addition of indexing primers. Amplification of the correct band size of 272 base 
pairs was not seen in exon 2. Exon 5 contains two bands at 291 base pairs and 256 base pairs 
indicates the presence of the orginal amplicon and amplicon + index respectively. 
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3.1.3 KCNQ1ot1 PCR optimisation 
The KCNQ1ot1 primers (Table 2.1) have previously been employed in the Hore 
laboratory. Successful amplification and incorporation of indexes has been achieved 
using the KAPA HF DNA polymerase mix (Table 2.5) with the following thermal 
cycling parameters. 
92C, 2min; 25*(92C, 10s; 59C, 10s; 72C, 30s); 72C, 5min; 4C, infinite; 7*(92C, 10s; 
59C, 10s; 72C, 30s); 72C, 5min; 4C, infinite. 
Figure 3.3a shows successful amplification of the KCNQ1ot1 locus using bisulfite 
treated B6xSD7 DNA. The presence of two bands, although faint, indicates successful 
incorporation of the unique indexes to the template sequence. Sequencing with the 
Illumina MiSeq system was used to confirm the successful index incorporation. 
However, this protocol proved inconsistent, especially when using low concentration 
DNA as a template. Increasing the number of cycles in the second round of PCR to ten 





Figure 3.3 Incorporation of unique indexes into KCNQ1ot1 amplicon 
Agarose gel electrophoresis analysis of the KCNQ1ot1 amplicon (446 base pairs) after two 
successive rounds of PCR, where (a) Seven additional cycles were used to incorporate indexes, 
n=3, or (b) Ten additional cycles were used to incorporate indexes, n=5 
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3.2  B6xSD7  
3.2.1 B6xSD7 Cell line establishment and antioxidant treatment 
The B6xSD7 cell line was first grown in several different culture media. These 
included: 
- Serum + 2i/LIF 
- Serum + LIF (in the absence of 2i) 
- N2B27 + 2i/LIF 
In serum + LIF conditions, the cells formed flattened, spread out colonies. However, in 
Serum +2i/LIF and N2B27 +2i/LIF conditions well defined circular colonies typical of 
naïve embryonic stem cells were observed (Ying et al., 2008). The B6xSD7 cell line 
appeared to be sensitive to N2B27 + 2i/LIF, as cultures would often arrest and 
subsequently crash after a few days in this condition. However, there appeared to be no 
substantial difference in growth rate between serum + LIF and serum + 2i/LIF 
conditions. Considering this, serum + 2i/LIF was used for antioxidant treatments 
because it induces naïve pluripotency, as opposed to the primed pluripotency of 
classical ES cells grown in the absence of 2i (Ying et al., 2008, Nichols and Smith, 
2009). This is of particular importance as classically grown ES cells have varied gene 
expression patterns within the population, while naïve cells have homogenous gene 
expression (Wray et al., 2010).  
  B6xSD7 cells were incubated in serum + 2i/LIF conditions for 168 
hours (7 days) before antioxidant treatment to induce naïve pluripotency and 
subsequent homogenous gene expression. ES cells were treated with various 
concentrations of ascorbate and hydroquinone (Table 3.1) for 72 hours. Hore et al, 
(2016) demonstrated that either 50 ng/μL of ascorbate or 50μM of hydroquinone 
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supplementation is sufficient to enhance TET activity in vitro. Thus, these 
concentrations served as the midpoint for treatment range. However, concentrations 
above 50 μM of hydroquinone proved toxic and no cell growth was detected. 
Therefore, 50 μM was set as the top concentration, and the range was scaled 
accordingly. Ascorbate treated samples showed inhibited cell growth at concentrations 
over 100 ng/μL, with no live cells being detected in 400 ng/μL of ascorbate. 
Table 3.1 B6xSD7 antioxidant treatment range 
B6xSD7 antioxidant treatment range 
Ascorbate (ng/μL)  0 6.25 12.5 25 50 100 200 400 
Hydroquinone (μM)   0 0.78 1.56 3.13 6.25 12.5 25 50 
 
3.2.2 B6xSD7 - Bisulfite amplicon sequencing of KCNQ1 
I used bisulfite amplicon sequencing to assess the methylation patterns at the 
KCNQ1ot1 imprinted loci after treatment of each antioxidant. Two successive rounds 
of PCR, as described in sections 2.4 and 3.1.2, were employed to amplify and attach 
unique indexes to the KCNQ1ot1 region at each antioxidant concentration (Table 3.1). 
Three independent biological replicates were used. Amplification was not observed at 
all concentrations – specifically, only products of incorrect size were found when media 
was supplemented with 200-400 ng/μL of ascorbate (Figure 3.4). Samples treated with 
hydroquinone had variable levels of amplification, however bands at the correct 






Figure 3.4 B6xSD7 ascorbate and hydroquinone amplicon library generation 
Agarose gel electrophoresis analysis of amplicon libraries after cell treatment with either 
ascorbate or hydroquinone, n=3. ‘Double bands’ at 446 base pairs indicate KCNQ1ot1 
amplicons with and without indexes attached. The three bands between 100 and 200 base pairs 




































































































































































































































































Amplicons were sequenced in multiplex with the Illumina MiSeq system. The number 
of reads per samples for ascorbate treated cells per was extremely variable within 
biological replicates (Figure 3.5). This is expected however, as the number of reads 
parallels the respective band intensities seen in Figure 3.4, suggesting that the number 
of reads is proportional to the amount of DNA being sequenced.  
Unsurprisingly, less than 50 reads were recorded for any of the replicates treated 
with either 200 ng/μL or 400 ng/μL of ascorbate. However, most importantly, all other 
samples had over 500 reads, and all but four had more than 1000 reads.  
 
Figure 3.5 Read count from ascorbate treated cells. 
Bar chart displaying the read count for all samples treated with ascorbate (Asc), where the first 








































































































































































































All hydroquinone treated samples, with the exception of those treated with 0.78 
μM hydroquinone, produced very low read counts (Figure 3.6). Interestingly, the HQ0 
(0μM hydroquinone) replicates and Asc0 replicates (0ng/μL ascorbate) had drastically 
different read counts despite having the same culture conditions. This suggests that the 
DNA extraction and bisulfite conversion, which occurred separately between the two 
treatment samples, resulted in decreased DNA yield in the hydroquinone samples, but 
not the ascorbate samples. 
 
Figure 3.6 Read count from hydroquinone treated cells 
Bar chart displaying the read count for all samples treated with hydroquinone (HQ), where the 









































































































































































































3.2.2.1 Bisulfite conversion efficiency 
The bisulfite chemical preferentially deaminates unmodified cytosines to uracil. 
Conversion efficiency can be altered by reaction conditions and reagent quality; thus, it 
is important to assess conversion efficiency for each reaction. The majority of DNA 
methylation in vertebrates is found within the CpG context, thus non-CpG sites can be 
used to approximate conversion efficiency provided DNA methylation levels are low in 
this context. Non-CpG methylation is enriched within classically grown mammalian ES 
cells, due to high DNMT3a and DNMT3b enzyme expression (Ramsahoye et al., 2000, 
Lee et al., 2017). However, downregulation of all DNMT enzymes contributes to low 
methylation levels in naïve ES cells grown under 2i conditions (Choi et al., 2017, von 
Meyenn et al., 2016, Lee et al., 2014b, Habibi et al., 2013, Ficz et al., 2013), resulting 
in non-CpG methylation levels of ~0.1%. Thus, non-CpG conversion rate is likely a 
good measure of overall bisulfite conversion efficiency for naïve ES cells.  
Both hydroquinone and ascorbate treated samples achieved extremely high 
conversion efficiencies (Figure 3.7), with all but one sample (HQ_50) showing 
conversion rates of 99.7% or higher. Considering the 0.1% non-CpG methylation 
reported by Habibi et al, (2014), it appears there was almost complete bisulfite 
conversion across all samples, suggesting that the CpG methylation patterns observed 





Figure 3.7 B6xSD7 Bisulfite conversion efficiency 
The mean bisulfite conversion efficiency for ascorbate (Asc) and hydroquinone (HQ) treated 
samples, as determined by the ratio of unconverted to converted cytosines in the non-CpG 
context (n=3, ±S.D.). The final concentration of supplemented Asc or HQ (ng/mL or µM 
respectively) is indicated for each sample.  
 
3.2.2.2 Allele Frequencies.  
The relative frequencies between maternal (B6) and paternal (SD7) alleles in the 
B6xSD7 samples were recorded to (a) determine allele specific methylation patterns, 
and to (b) determine if any amplification bias had occurred. To achieve this, the allelic 
differences (Figure 2.1) were used to isolate parent specific reads. Interestingly, some 
samples (Asc0, Asc6.25, and Asc25 + HQ0.78 + HQ6.25) had significantly more 
paternal reads than maternal reads, while the remaining samples had no significant 
difference. Ascorbate treated samples tended to trend towards more paternal alleles 


























amount of variation. It is possible that the difference seen in the latter two samples is 
due to (a) very low read counts, and (b) ‘clonal expansion’ during PCR amplification 
(Figure 3.9). Clonal expansion is where one parental allele gets preferentially amplified 
because of low template concentration. Clonal amplification can also be detected by 
analysing the diversity of methylation patterns within a population of fragments which 
is discussed later in the results (section 3.2.3).  
 Hydroquinone treated samples also appeared to trend towards higher paternal 
allele reads than maternal reads. While only two were statistically different from 
expected (HQ0.78 and HQ6.25), most  hydroquinone samples showed high variation 
between replicates indicating skewed amplification indicative of clonal expansion 
(Figure 3.8b). The paternal allele is six base pairs shorter than the maternal allele. This 
difference may account for the somewhat apparent skew towards the paternal allele.  
       a                                                  b   
 
Figure 3.8 KCNQ1ot1 allele frequencies in B6xSD7 
Relative parental allele frequencies after sequencing in the B6xSD7 cell line. The maternal 
(pink) and paternal (blue) alleles for (a) ascorbate and (b) hydroquinone treated samples is 
shown (n=3, ±S.D.). Two-way students t-test.      
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3.2.3 Clonal expansion 
Amplicon bisulfite sequencing is prone to clonal amplification if low amounts of 
starting material are used. Given skewed amplification of parental alleles from B6xSD7 
template, I suspected that clonal amplification may be prevalent in my dataset, 
particularly for the high ascorbate concentrations (where there was a lot of cell death) 
and the hydroquinone samples. To explore this further, I examined the patterns of 
methylation for each sample and identified where clonal amplification was likely 





Figure 3.9 Clonal Expansion 
Clonal expansion of the maternal allele of B6xSD7 after ascorbate treatment. (a) An example 
of a library with no clonal expansion after amplification (25 ng/μL of ascorbate), (b) An 
example of a library with clonal expansion after amplification (400 ng/μL of ascorbate). Clonal 
amplification is exemplified by repeated patterns throughout the entire library. 
  












































































3.2.4 Effects of ascorbate on KCNQ1ot1 
In this experiment, the methylation patterns at the KCNQ1ot1 locus were examined 
after ascorbate treatments across several concentration ranges (Table 3.1). KCNQ1ot1 
is a maternally controlled region, meaning the maternal allele is methylated, while the 
paternal is unmethylated (Royo and Cavaille, 2008).  
By isolating the reads from the maternal alleles only, I compared the 
methylation patterns at each level of ascorbate treatment. Asc200 and Asc400 both 
showed signs of major clonal amplification, as seen by consistently repeated 
methylation patterns and as a result were excluded from any further analysis. 
Surprisingly, even with no ascorbate treatment, there was only a maximum of 55% 
CpG methylation across all samples and all three biological replicates. 2i conditions are 
known to induce demethylation at ICRs, however, this usually takes many passages and 
prolonged culture (Choi et al., 2017), as opposed to the 10 days of culture in 2i used in 
these experiments, underlining how unpredictable imprint stability can be under 2i 
conditions. .  
 Interestingly, ascorbate treatment appeared to cause a decrease in DNA 
methylation, although the effects were subtle. All levels of ascorbate supplementation 
except 100 ng/nL caused significant demethylation when compared to the control 
individually, however, significance was lost for all samples except the 25 ng/mL level 
following Bonferoni correction for multiple comparison (Figure 3.10). One unexpected 
result was that a clear response to ascorbate was not obvious. I hypothesized that higher 
concentrations of ascorbate would result in more rapid demethylation, however ES cells 
with 100 ng/µL ascorbate had the second highest amount of methylation behind 6.25 
ng/μL of ascorbate when compared to the control, despite having twice the amount of 
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ascorbate as the next highest treatment. This data suggests that there may be an optimal 
range somewhere between 12.5ng/μL - 100 ng/μL where demethylation can occur 
under ascorbate supplementation. Indeed, Blaschke et al, (2013) report no significant 



















6.25 ng/µL 0.1435 × × 
12.5 ng/µL 0.0546  × 
25 ng/µL 0.0074   
50 ng/µL 0.0208  × 
100 ng/µL 0.1139 × × 
 
 
Figure 3.10 Effect of ascorbate treatment on KCNQ1ot1 methylation  
(a) Bar graph depicting overall methylation percentage at KCNQ1ot1 (n=3, ±S.D.) * adjusted 
p-value < 0.01. (b) All treatments were compared to 0 ng/μL using a two-tailed unpaired t-test 






















3.2.5 Effects of hydroquinone on KCNQ1ot1 
The effect of hydroquinone on maternal methylation stability at the KCNQ1ot1 locus 
was also tested. Similarly, to the ascorbate treated cells, loss of methylation was present 
in maternal alleles, even in the control, suggesting prior loss of methylation. 
Unfortunately, all samples presented with signs of clonal amplification during 
sequencing, as shown by repeated methylation patterns and low read diversity 
(Supplementary Figure 4), as well as high variation in parental allele frequency (Figure 
3.8). Unsurprisingly, due to the extremely high variation between biological replicates 
(Figure 3.11a) no statistically significant effect was observed as a result of 
hydroquinone treatment. By the same token, this data cannot be used to infer the 
opposite conclusion; I cannot be sure that hydroquinone does not have an effect on ICR 




a                                                                                    b 
 
Figure 3.11 Effect of hydroquinone treatment on KCNQ1ot1 methylation 
(a) Bar graph depicting overall methylation percentage at KCNQ1ot1 (n=3 ± S.D.). High 
variance is an additional indicator of clonal expansion. (d) All treatments were compared to 0 
ng/μL using a two-tailed unpaired t-test with Bonferroni correction for multiple comparisons. * 
adjusted p-value < 0.01. 
 
3.3 TET triple Knockout 
3.3.1 TET TKO mTET1-CD cell line establishment 
Up until this point it had been assumed that antioxidant treatment was eliciting changes 
by enhancing TET activity. In order to explore this further, the TET TKO mTET1-CD 
cell line was simultaneously tested. This cell line does not possess any endogenous 
TET protein, as all three TET variants contain loss of function mutations in the catalytic 
domain (Hu et al., 2014). However, in addition to this, the TET TKO mTET1-CD line 
has been transfected with functional TET1, as well as the reporter protein mCherry, 
under the control of a doxycycline inducible promotor; allowing for rescued TET 
expression in a controlled manner (Hore et al., unpublished).  
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Similarly to the B6xSD7 line, the TET TKO mTET1-CD cells were initially grown in 
three different media: 
- Serum + 2i/LIF 
- Serum + LIF (in the absence of 2i) 
- N2B27 + 2i/LIF 
There were no observable differences in growth between serum + 2i/LIF or serum + 
LIF in the absence of 2i. However, the growth rate was inhibited by N2B27 + 2i/LIF, 
but no culture crashes were observed like in B6xSD7. As a result, both serum + 2i/LIF 
and N2B27 + 2i/LIF media were used in the current experiment.  
 Antioxidant treatment in the TET TKO line covered a similar range as B6xSD7, 
but fewer increments were used (Table 3.2). In addition, 1 μM of doxycycline was 
added to the culture media to induce TET1 expression.  
Table 3.2 TET TKO mTET1-CD antioxidant treatment range 
TET TKO mTET1-CD antioxidant treatment range 
Ascorbate (ng/μL)  0 12.5 50 





3.3.2 Parental origin identification of the Impact locus in the TET TKO 
cell line 
Prior to the beginning of this project, it was unknown if the TET TKO cell line 
contained any allele specific differences at any ICRs. However, it was possible there 
were SNPs at the impact locus, similar to those in the V6.5 cell line (Figure 2.1). This is 
because the TET TKO line has a mixed genetic background, primarily of the 129/sv 
strain, but also containing some C57BL6 (B6) (Figure 3.12). It was possible that the 
Impact locus contains one B6 allele and one 129/sv allele, therefore providing me a 
way to distinguish the maternal and paternal alleles apart. 
 To determine if this was the case, the genomic region of exon 2 and exon 5 from 
Impact were amplified using PCR (primers detailed in Table 2.3) and analysed via 
Sanger sequencing. Unfortunately, no SNPs were observed in either exon 2 or exon 5 
(Figure 3.13). Both exons contained the 129/sv variant, indicating that the Impact locus 
in the TET TKO line is only of 129/sv descent. Interestingly, this contrasts with 
information supplied by the creators of this line which states the TET TKO is a 






Figure 3.12 Derivation of the TET triple knockout cell line 
Schematic diagram depicting the genetic background of the TET TKO cell line. Specifically, a 
TET1 knockout was performed in a 129/sv ES cell line, while a TET2 knockout was performed 
in a B6x129/sv ES cell line. The two knockout lines were crossed to produce a TET 1/2 double 








Figure 3.13 SNP analysis of the Impact locus in TET TKO cells 
Chromatogram depicting the location of known SNPs between B6 and 129/sv mouse strains at 
(a) exon 2 and (b) exon 5 of the Impact locus. In both cases, the SNPs in question are clearly 




3.3.3 TET1 overexpression and FACS analysis. 
TET1 overexpression was performed by the addition of 1 μM doxycycline to culture 
media 72 hours before harvesting. To isolate and collect cells with either very low or 
very high TET1 expression fluorescence activated cell sorting was used. The following 
gating parameters were used: 
- Samples were gated by FSC-Area v FSC-Height (Figure 3.14a) and SSC-Area 
and SSC-Height (Figure 3.14b) to remove double cells.  
- Gating for cells with low DAPI expression ensured only live cells were selected 
(Figure 3.14c). 
- Gating for cells with a 1:1 ratio of FSC-Area to SSC-Area selected cells based 
on size and morphology, excluding what is likely cellular debris (Figure 3.14d). 
- Gating for cells with very low mCherry fluorescence (and therefore low TET1 
expression) and cells with very high mCherry fluorescence (and therefore high 
TET1 expression), excluding those with moderate fluorescence (Figure 3.14e). 
20,000 cells were collected for each antioxidant treatment range, 10,000 of each high 















Figure 3.14 FACS of TET TKO cells after induction of TET1 expression. 
Example of FACS gating after induction of TET1 expression in TET TKO cells. Cells were 
gated to remove (a- b) doublets (c) dead cells (d) cellular debris, and to select for (e) cells with 
very high or very low TET1 expression.  
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3.3.4 TET TKO - Bisulfite amplicon sequencing of KCNQ1ot1 
Considering the Impact locus did not contain any allele specific SNPSs, and the 
KCNQ1ot1 PCR had to be optimised, KCNQ1ot1 was the locus of interest examined 
in this experiment. Using the PCR protocol described in 3.1.2, bisulfite amplicons 








Figure 3.15 TET TKO ascorbate and hydroquinone amplicon library creation 
Agarose gel electrophoresis analysis of amplicon libraries after cell treatment with either 
ascorbate or hydroquinone, n=3. ‘Double bands’ at 446 base pairs indicate KCNQ1ot1 
amplicons with and without indexes attached. The three bands between 100 and 200 base pairs 


































































































































































































The number of reads varied drastically between the samples (Figure 3.16). While some 
samples had more than 2000 reads, many did not surpass 500 reads. Considering this, it 
may be difficult to reach accurate conclusions from samples with extremely low read 
counts (i.e below 100).  
 
Figure 3.16 Read count from TET TKO mTET1-CD cells 
Bar chart displaying the read count for all samples treated with ascorbate (Asc) and 
hydroquinone (HQ). + and – signs represent high and low TET expression respectively. The 
final concentration of supplemented Asc or HQ (ng/mL or µM respectively) is indicated for 
each sample.  
 
3.3.4.1 Bisulfite conversion efficiency 
Bisulfite conversion efficiency was determined using the same methodology as in 
section 3.2.2.1. All samples, with the exception of Asc50 High TET, have very high 
conversion efficiencies in line with those discussed previously. Asc50 High TET 



























































































































































































































































conversion efficiencies over 99.5%. Due to this, Asc50 High-TET_3 was removed from 
further analysis (Figure 3.17). 
 
 
Figure 3.17 TET TKO mTET1-CD bisulfite conversion efficiency 
The mean bisulfite conversion efficiency for ascorbate (Asc) and hydroquinone (HQ) treated 
samples, as determined by the ratio of unconverted to converted cytosines in the non-CpG 
context (n=3, ±S.D.). The final concentration of supplemented Asc or HQ (ng/mL or µM 
respectively) is indicated for each sample.  
 
3.3.4.2 Methylation patterns 
Despite high bisulfite conversion efficiency, all TET TKO samples presented with low 
read counts and repeated methylation patterns indicative of high levels of clonal 
expansion. Examples of these are given in supplementary Figure 5. This was enough to 
skew the data and prevent accurate conclusions from being drawn. Therefore, all TET 






























4 CHAPTER FOUR: DISCUSSION 
Naïve ES cells and iPSCs have the potential to revolutionise the fields of regenerative 
medicine and mammalian transgenics. Artificial enhancement of TET enzyme activity 
via antioxidant supplementation can dramatically improve the reprogramming of 
differentiated cells to a naïve state of pluripotency (Coulter et al., 2013, Blaschke et al., 
2013); however, the mechanism by which this occurs and its incidental effects are still 
being explored. 
In this study, a potential negative consequence of TET-enhanced 
reprogramming was examined; specifically, its effect on genomic imprinting stability. 
This involved supplementing naïve ES cells with two different antioxidants, either 
ascorbate or hydroquinone, to boost TET activity through Fe2+ recycling within the 
TET catalytic domain. The methylation patterns at the KCNQ1ot1 locus were 
subsequently examined. Here, I have shown that ascorbate induces significant removal 
of DNA methylation. However, due to technical difficulties, I was unable to determine 
if this effect was also present during hydroquinone supplementation. 
 
4.1 High throughput amplicon bisulfite sequencing 
4.1.1 Advantages of multiplex bisulfite amplicon sequencing 
To adequately answer the research question of this study the epigenetic status of a large 
number of samples needed to be analysed. To achieve this, I employed a high 
throughout multiplex sequencing approach similar to that recently used for HLA typing 
(Lange et al., 2014). However, what made my approach unique was (1) amplification 
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from bisulfite treated template, and (2) a novel two-step PCR whereby my region of 
interest was first amplified for 25 cycles, and then unique indexes complementary to 
the initial were added prior to another 10 cycles (Figure 2.2). The latter approach 
drastically reduced library preparation time compared with regular library construction. 
Double ended indexing was also a feature of the approach (i.e. having unique indexes at 
both the 5’ and 3’ end of the PCR amplicon), allowing potentially hundreds of different 
samples to be sequenced concurrently using the Illumina MiSeq system. Used together, 
these technical advances are considerably more powerful and faster than the plasmid 
vector cloning and Sanger sequencing techniques commonplace only a few years ago.  
  
4.1.2 Limitations of multiplex bisulfite amplicon sequencing 
Despite the positive features of multiplex bisulfite amplicon sequencing, there are 
several limitations that need to be addressed. The most prevalent of these during this 
study was clonal amplification in the TET TKO samples (Figure 3.9 and supplementary 
Figure 5). This occurs when a single sequence forms a disproportionate number of 
clusters compared to the other sequences within the same sample. When performing 
quantitative analyses, as was this case in the present study, clonal amplification makes 
any sequence affected appear more prevalent and thus skews the data. As a result, 
clonal amplification often renders data useless. 
 The biggest cause of clonal amplification is likely low template concentrations 
(Figure 3.6 and Figure 3.16). Therefore, improving initial template concentrations may 
be the best way to overcome this issue. While achieving higher cell numbers can be 
difficult when sorting cells with flow cytometry or FACS (for example, only 10,000 
cells were gathered for each treatment during FACS), another solution may be a less 
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harsh bisulfite treatment. While this may reduce the overall bisulfite conversion 
efficiency, it may improve the DNA yield post conversion. This is because bisulfite 
conversion can lead to degradation of up to 90% of template DNA (Grunau et al., 
2001).  
 However, it is possible that clonal amplification can still occur despite a higher 
amount of starting template. Therefore, it is also important not only to minimise the 
clonal amplification, but also be able to detect it when it is present. In this study, I 
identified clonal amplification by identification of amplification that favoured one 
allele over the other (Figure 3.8), and by analysis of the methylation patterns coming 
from the reads (Figure 3.9). While it was usually obvious when clonal amplification 
was present, the amount of diversity within each library was not formally quantified. In 
order to improve this, I would suggest using unique molecular identifiers within the 
gene-specific primers. This would involve the addition of a random 4-6 base pair 
sequence into the primers so that each amplicon would contain two indexes, one 
pertaining to the specific sample it came from, and another specific to that amplified 
molecule (Figure 4.1). This would allow any reads containing the same secondary 
index to be removed and give confidence that no read has been accounted for more than 




Figure 4.1 Addition of unique molecular indexes to PCR amplicons 
Library generation would remain largely the same, however each amplicon would now have its 
own unique index to eliminate the effects of clonal expansion during sequencing. 
 
 
4.2 Analysis of ascorbate treatment on KCNQ1ot1 
4.2.1 The relationship between ascorbate, TET, and genomic imprinting 
stability 
The purpose of this experiment was to determine if enhanced TET activity 
unintentionally results in the demethylation of the KCNQ1ot1 locus, subsequently 
resulting in loss of imprinting. I treated naïve B6xSD7 ES cells with various ascorbate 
concentrations ranging from 0 ng/μL to 400 ng/μL (Table 3.1), predicting that as the 
ascorbate concentration was increased there would be a corresponding, dose dependant 
loss of DNA methylation. 
Interestingly, only samples that had been treated with 25 ng/μL had a statistically 
significant loss of methylation following correction for multiple testing; however, it 
appeared that samples between the ranges of 12.5 ng/μL to 50 ng/μL also lost 
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methylation that was nearing significance (i.e. p<0.05). In line with this, ICRs are 
resistant to the initial wave of demethylation following fertilization in vivo (Morgan et 
al., 2005), as well as the hypomethylation that occurs in naïve ES cells cultured in 2i. 
However, ICR demethylation does occur in 2i cultured cells, but much later than most 
other global demethylation events (Choi et al., 2017).  
Surprisingly, loss of methylation did not appear to occur at 100 ng/μL of ascorbate; 
the highest concentration tested that did not show signs of clonal amplification. These 
results conform to the observations of Blaschke et al, (2013) who report no significant 
loss of methylation at ICRs after 100 ng/μL of ascorbate treatment. Interestingly, the 
aforementioned paper relied upon a single treatment concentration and concluded that 
enhanced TET activity through ascorbate supplementation had no significant effect on 
ICR stability. The results of the present study challenge this conclusion. Instead, I 
suggest that ascorbate induces a dose dependant effect on TET enzymatic activity 
where activity is highest in a ‘sweet spot’ of 12.5 ng/μL to 50 ng/μL. Therefore, I 
propose that TET-induced demethylation is modulated by ascorbate such that 
enzymatic activity increases to a peak level of activity at approximately 25 ng/μL of 
ascorbate, before subsequently lowering as ascorbate concentration increases (Figure 
4.2). This coincides with the observation that knockout serum replacement (KSR), a 
common media used in ES cell and iPSC culture which contains ascorbate, induces 
increased aberrant methylation patterns at imprinted loci when compared to standard 
serum-based culture media (Lee et al., 2018).  
While the PBAT technique was employed to assess global CpG methylation levels 
at each antioxidant concentration level, due to time constraints optimization was not 
completed in time and no results were gathered. However, Blaschke et al, (2013) have 
reported that ascorbate still improves TET-induced demethylation at 100 ng/μL on a 
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genome wide scale. Therefore, it is possible that any decrease in activity is minimal but 
still enough to be reduce activity levels below the threshold required for loss of 
methylation at ICRs.  
 This apparent decrease in TET activity during higher concentrations of 
ascorbate seems somewhat paradoxical, however I propose two hypotheses that I would 
like to test during future research in this subject area: 
(1) Antioxidants such as ascorbate improve TET activity by enhancing Fe2+ 
recycling, but at higher concentrations inhibit the oxidation reaction of 5mC to 
5hmC such that it is below the threshold for demethylation at ICRs. 
(2) Ascorbate has a dual function as an antioxidant and a pro-oxidant in some 
contexts (Rietjens et al., 2002). At higher concentrations, this balance shifts 
towards a pro-oxidant state such that there is not enough Fe2+ to increase TET 





Figure 4.2 The relationship between ascorbate, TET, and imprinting stability 
The proposed relationship between ascorbate supplementation, TET activity, and genomic 
imprinting stability in which there is a ‘sweet spot’ of enhanced activity that crosses a threshold 
and enables demethylation at imprint control regions. 
 
 
4.2.2 Implications of the TET TKO experiment 
Due to the TET TKO experiment suffering from clonal amplification, it is 
potentially difficult to say the effects observed in the B6xSD7 cell line under ascorbate 
treatment were due to TET activity alone. Ascorbate has many roles within the cell, and 
are likely to enhance the activity of other Fe2+ dependant dioxygenase enzymes. One 
class of these enzymes is the Jumanji (Jmj) histone demethylases, which remove 
methylation from histones by oxidation in a similar fashion to TET removal of 
methylated cytosine (Young et al., 2015, PMID: 25974700).  Despite this, the 
overwhelming consensus from current literature is that global DNA methylation levels 
are directly impacted by ascorbate in a TET-dependent manner because removal of 
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TET abolishes ascorbate-induced global demethylation (Blaschke et al., 2013, Minor et 
al., 2013). Nevertheless, my research was not able to exclude the possibility that 
ascorbate has indirect effects on imprint stability which are independent of TET; an 
aspect of which should be further tested in subsequent experiments.  
 
 
4.3 Other enhancers of TET 
While I was unable to determine if hydroquinone supplementation induced TET-
mediated demethylation at ICRs, the results from the ascorbate experiment show it can 
occur. As a result, any enhancer of TET may have the ability to cause loss of imprinting 
in pluripotent stem cells or IVF embryos, with the possibility of an additive effect 
across all components occurring. Perhaps the best example of this is retinoic acid (RA) 
which can work synergistically with ascorbate to improve TET activity and induce 
reprogramming. RA directly upregulates the expression of TET2 and TET3 by binding 
to a retinoic acid receptor element upstream of their promotors, causing subsequent 
transcription (Hore et al., 2016).  
It is likely that due to the compounding action of these two vitamins that the 
imprinting instability reported in this study would be greatly amplified. Therefore, 
media design for future iPSC and IVF embryo culture should not consider the amount 
of ascorbate present within the media, but consider what effect the media composition 





4.4 Implications for regenerative medicine and in vitro 
Fertilization 
The results of the current research have uncovered the potential danger of enhancing 
TET activity in pluripotent stem cells. In the introductory chapter of this thesis I 
discussed the consequences of aberrant methylation patterns at ICRs and the subsequent 
loss of imprinting. Specifically, it appears to be a driver for many cancers, in particular 
myeloid leukaemia (Jelinic and Shaw, 2007). So, while iPSCs are expected to be at the 
forefront of personalised regenerative medicine, and faster derivation of these cells will 
result in faster treatment for patients, it is a priority to maintain the health of these cells 
above all else. Any affected iPSCs will be unsafe for regenerative medicine 
applications. Therefore, if ascorbate-induced enhancement of TET is to be used during 
the reprograming of iPSCs then media conditions must be designed with this in mind, 
especially when considering given the relationship between LOI and myeloid 
leukaemia, and that one of the most common forms of stem cell therapy employed at 
the moment are haemopoietic stem cell transplantations (Passweg et al., 2012, Jelinic 
and Shaw, 2007).    
Children born to assisted reproductive technologies (ART), such as in vitro 
fertilization (IVF), have a much greater risk of suffering from imprinting disorders, 
specifically Beckwith–Wiedemann syndrome (BWS) (Amor and Halliday, 2008). BWS 
is often caused by hypomethylation of several imprinted loci, including H19/IGF-2 and 
KCNQ1ot1, resulting in biallelic expression. This results in an increased risk of 
childhood cancer, as well as an array of congenital defects (Amor and Halliday, 2008, 
Chiesa et al., 2012). It is nine times more common in IVF conceived children (Halliday 
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et al., 2004), implying that people conceived via IVF are more prone to aberrant 
imprinting when compared to naturally conceived individuals. 
Given that culture media is heavily deterministic of phenotype in ES cells, it is 
possible that the media used to culture IVF embryos may also have an impact on their 
epigenetic stability. Indeed, recently it was shown that porcine embryos cultured in 
standard, commercially available IVF media experienced greater aberrations in DNA 
methylation than in embryos cultured in reproductive fluid, or in vivo (Canovas et al., 
2017). Unfortunately, because the media used to culture IVF embryos is becoming 
increasing commercialized, proprietary reasons have prevented the exact formulations 
of these media from being made public. However, some IVF culture media do contain 
ascorbic acid (Chronopoulou and Harper, 2015), however, it is often not known how 
much ascorbate is being added to media. Given the results from this study, it is possible 
that ascorbate-induced TET activity is responsible for the aberrant methylation 
observed in IVF embryos. Therefore, greater exploration into the effects of culture 
media, especially ascorbate and other antioxidants, on IVF embryos is required to 
improve culture media conditions and the overall health of those conceived from 
assisted reproductive technologies.  
 
4.5 Concluding remarks 
This study was part of an overall research project aiming to understand the properties of 
pluripotent stem cells and how to best harness their developmental potency. The use of 
small molecules that enhance erasure of epigenetic memory through the TET enzymes 
has drastically improved the rate at which differentiated cells can be reprogrammed 
back to the naïve state of pluripotency. However, the results of the ascorbate treatment 
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experiment show that this technique has downsides which effect the safety and viability 
of pluripotent cells in regenerative medicine. Despite the remainder of the study being 
hampered by technical difficulties, my results here can add to the current collection of 
literature describing the effects of culture media components on the phenotype of early 
mammalian embryos and ES cells. In doing so, this may allow the rational design of 
culture media that can improve both the efficiency and safety of naïve ESCs and 
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Supplementary Figure 1 Full KCNQ1ot1 amplicon sequence 
The KCNQ1ot1 amplicon nucleotide sequence. (a) Maternal (C57BL/6) allele (b) 

















Supplementary Figure 2 Full Impact amplicon sequences 
The Impact cDNA nucleotide sequence for (a) exon 2, and (b) exon 5. SNPs are 











Supplementary Figure 3 KCNQ1ot1 methylation patterns from ascorbate treated B6xSD7 
cells 
Examples of methylation patterns from B6xSD7 cells treated with (a) 0 ng/µL, (b) 25 











Supplementary Figure 4 KCNQ1ot1 methylation patterns from hydroquinone treated 
B6xSD7 cells 
Examples of methylation patterns from B6xSD7 cells treated with (a) 0 µM, (b) 25 


































Supplementary Figure 5 KCNQ1ot1 methylation patterns from TET TKO cells 
Examples of methylation patterns from TET TKO cells treated with either ascorbate 
(Asc) or hydroquinone (HQ). The final concentration of supplemented Asc or HQ 
(ng/mL or µM respectively) is indicated for each sample. Figures specified as low TET 
were from cells with low mCherry fluorescence, while figures specified as high TET 





Supplementary Figure 6 Bioline HyperLadder™ molecular weight maker sizes 




Supplementary Table 1 FBS-based ESM recipe 
FBS-based ESM Recipe 
Components Volume 
DMEM, high glucose, pyruvate (Gibco, 11995-065) 215 mL 
FBS (Moregate Biotech FBS sterile filtered, MG-FBSF-500ML) 37.5mL 
Penicillin-Streptomycin (100X, Life Tech, 15140-122) 2.5mL 
MEM Non-Essential Amino Acids Solution (100X, Life Tech, 
11140-050) 
2.5mL 
2-Mercaptoethanol (55 mM, Life Tech, 21985-023) 0.25mL 
Total 257.75mL 
LIF 10ug/mL (1000x, diluted in PBS + 0.1% BSA. Sourced from 
CSCR, Sally Lees) 






Supplementary Table 2 N2B27 ESM recipe 
N2B27 ESM Recipe 
Components Volume 
DMEM/F12 (Gibco 21331-020) 100mL 
Neurobasal (Gibco 21103-049) 100mL 
N2 (Stem Cells SF-NS-01-005) 1mL 
B27 (Gibco 17504-044) 2mL 
L-Glutamine (Gibco 25030-024) - avoid repeat thawing at 37 degrees 2mL 
P/S (Gibco, cat 15140-122) 2.2mL 
2-Mercaptoethanol (31350-010) 0.22mL 
Total 207.42mL 
LIF 10ug/mL (1000x, diluted in PBS + 0.1% BSA. Sourced from 
CSCR, Sally Lees) 
1uL per mL of 
medium 
 
Supplementary Table 3 2i mixture recipe 
2i Mixture 
Components Volume 
CHIR99021 (Stemgent, 04-0004 - make 10mM solution 
by adding 428.9uL of DMSO) 
0.3uL per mL of ESM (final conc. 
3uM) 
PD0325901 (Stemgent, 04-0006 - make 10mM solution 
by adding 414.8uL of DMSO) 





Supplementary Table 4 cell culture dish size and volume 
Dish Media Accutase Area (cm2) 
Diameter cm 
(actual) 
96-well plate 200 uL/well 30-50 uL 0.3 0.6 
24-well plate 1 mL/well 200 uL 1.8 1.5 
12-well plate 2 mL/well 300uL 3.5 2.1 
6-well plate 3-4 mL/well 400 uL 9.6 3.5 
6-cm dish 6 mL 0.6 mL 21.2 5.2 
10-cm dish 10 mL 1 mL 60 8.7 
15-cm dish 30 mL 3 mL 154 14 
 
Supplementary Table 5 cell seeding densities 




B6xSD7 Serum + 2i/LIF 12-well plate 200,000 100,000 
N2B27 + 2i/LIF 12-well plate 200,000 100,000 
V6.5 Serum + 2i/LIF 12-well plate 100,000 50,000 
N2B27 + 2i/LIF 12-well plate 100,000 50,000 
TET TKO 
mTET1-CD 
Serum + 2i/LIF 10 cm dish 2,750,000 275,000 





Supplementary Table 6 freezing media recipe 
Freezing media recipe 
Component Volume 
FBS-based ESM (without 2i) 37.5 mL 
FBS (15% final concentration) 7.5 mL 
DMSO (10% final concentration) 5 mL 
Total 50 mL 
 
 
Supplementary Table 7 forward priming index sequences 





FPI 06 ACATTGGC 





Supplementary Table 8 reverse priming index sequences 




Reverse priming index  
01 AACGTGAT 25 AGTCACTA 49 GATAGACA 73 AATGTTGC 
02 AAACATCG 26 ATCCTGTA 50 GCCACATA 74 ACACGACC 
03 ATGCCTAA 27 ATTGAGGA 51 GCGAGTAA 75 ACAGATTC 
04 AGTGGTCA 28 CAACCACA 52 GCTAACGA 76 AGATGTAC 
05 ACCACTGT 29 CAAGACTA 53 GCTCGGTA 77 AGCACCTC 
06 ACATTGGC 30 CAATGGAA 54 GGAGAACA 78 AGCCATGC 
07 CAGATCTG 31 CACTTCGA 55 GGTGCGAA 79 AGGCTAAC 
08 CATCAAGT 32 CAGCGTTA 56 GTACGCAA 80 ATAGCGAC 
09 CGCTGATC 33 CATACCAA 57 GTCGTAGA 81 ATCATTCC 
10 ACAAGCTA 34 CCAGTTCA 58 GTCTGTCA 82 ATTGGCTC 
11 CTGTAGCC 35 CCGAAGTA 59 GTGTTCTA 83 CAAGGAGC 
12 AGTACAAG 36 CCGTGAGA 60 TAGGATGA 84 CACCTTAC 
13 AACAACCA 37 CCTCCTGA 61 TATCAGCA 85 CCATCCTC 
14 AACCGAGA 38 CGAACTTA 62 TCCGTCTA 86 CCGACAAC 
15 AACGCTTA 39 CGACTGGA 63 TCTTCACA 87 CCTAATCC 
16 AAGACGGA 40 CGCATACA 64 TGAAGAGA 88 CCTCTATC 
17 AAGGTACA 41 CTCAATGA 65 TGGAACAA 89 CGACACAC 
18 ACACAGAA 42 CTGAGCCA 66 TGGCTTCA 90 CGGATTGC 
102 
 
19 ACAGCAGA 43 CTGGCATA 67 TGGTGGTA 91 CTAAGGTC 
20 ACCTCCAA 44 GAATCTGA 68 TTCACGCA 92 GAACAGGC 
21 ACGCTCGA 45 GACTAGTA 69 AACTCACC 93 GACAGTGC 
22 ACGTATCA 46 GAGCTGAA 70 AAGAGATC 94 GAGTTAGC 
23 ACTATGCA 47 AGTCACTA 71 AAGGACAC 95 GATGAATC 
24 AGAGTCAA 48 ATCCTGTA 72 AATCCGTC 96 GCCAAGAC 
 
